ONTOLOGY REPORT - ANNOTATIONS
Term: cyclosporin A
Accession: CHEBI:4031
Definition: A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Synonyms: exact_synonym: 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone related_synonym: (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl); 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]; 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone; Antibiotic S 7481F1; C62H111N11O12; CC[C@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C; Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl); Cyclosporine; Gengraf; InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42+,43-,44+,45-,46+,47+,49+,50-,51+,52-/m1/s1; InChIKey=PMATZTZNYRCHOR-VJRYSDSKSA-N; Neoral; Sandimmune; ciclosporin; ciclosporina; ciclosporine; ciclosporinum alt_id: CHEBI:63586 xref_casrn: 59865-13-3 xref: Beilstein:3647785 "Beilstein Registry Number"; ChemIDplus:59865-13-3 "CAS Registry Number"; CiteXplore:11058832 "PubMed citation"; CiteXplore:11069928 "PubMed citation"; CiteXplore:11079273 "PubMed citation"; CiteXplore:11080188 "PubMed citation"; CiteXplore:11238591 "PubMed citation"; CiteXplore:11256490 "PubMed citation"; CiteXplore:11278005 "PubMed citation"; CiteXplore:11315347 "PubMed citation"; CiteXplore:11370709 "PubMed citation"; CiteXplore:11406057 "PubMed citation"; CiteXplore:11426833 "PubMed citation"; CiteXplore:11442023 "PubMed citation"; CiteXplore:11481617 "PubMed citation"; CiteXplore:11493684 "PubMed citation"; CiteXplore:11529914 "PubMed citation"; CiteXplore:11557554 "PubMed citation"; CiteXplore:11564166 "PubMed citation"; CiteXplore:11676831 "PubMed citation"; CiteXplore:11870366 "PubMed citation"; CiteXplore:12021257 "PubMed citation"; CiteXplore:12050171 "PubMed citation"; CiteXplore:12603598 "PubMed citation"; CiteXplore:12761440 "PubMed citation"; CiteXplore:12929192 "PubMed citation"; CiteXplore:12950728 "PubMed citation"; CiteXplore:14521916 "PubMed citation"; CiteXplore:14621732 "PubMed citation"; CiteXplore:14638917 "PubMed citation"; CiteXplore:14672695 "PubMed citation"; CiteXplore:14682659 "PubMed citation"; CiteXplore:14743390 "PubMed citation"; CiteXplore:15030555 "PubMed citation"; CiteXplore:15175101 "PubMed citation"; CiteXplore:15210365 "PubMed citation"; CiteXplore:15306697 "PubMed citation"; CiteXplore:15383526 "PubMed citation"; CiteXplore:15541012 "PubMed citation"; CiteXplore:15613074 "PubMed citation"; CiteXplore:15626898 "PubMed citation"; CiteXplore:15657176 "PubMed citation"; CiteXplore:1566062 "PubMed citation"; CiteXplore:15711594 "PubMed citation"; CiteXplore:15811524 "PubMed citation"; CiteXplore:15962181 "PubMed citation"; CiteXplore:16372476 "PubMed citation"; CiteXplore:16404634 "PubMed citation"; CiteXplore:16724420 "PubMed citation"; CiteXplore:16801218 "PubMed citation"; CiteXplore:16898534 "PubMed citation"; CiteXplore:17032751 "PubMed citation"; CiteXplore:17083576 "PubMed citation"; CiteXplore:17117422 "PubMed citation"; CiteXplore:17192032 "PubMed citation"; CiteXplore:17220244 "PubMed citation"; CiteXplore:17229932 "PubMed citation"; CiteXplore:17265451 "PubMed citation"; CiteXplore:17446460 "PubMed citation"; CiteXplore:17603747 "PubMed citation"; CiteXplore:18076075 "PubMed citation"; CiteXplore:18171316 "PubMed citation"; CiteXplore:18191430 "PubMed citation"; CiteXplore:18217899 "PubMed citation"; CiteXplore:18259730 "PubMed citation"; CiteXplore:18299432 "PubMed citation"; CiteXplore:18359899 "PubMed citation"; CiteXplore:18583716 "PubMed citation"; CiteXplore:18597363 "PubMed citation"; CiteXplore:18790203 "PubMed citation"; CiteXplore:18818682 "PubMed citation"; CiteXplore:18931077 "PubMed citation"; CiteXplore:18975184 "PubMed citation"; CiteXplore:19282398 "PubMed citation"; CiteXplore:19589783 "PubMed citation"; DrugBank:DB00091 "DrugBank"; KEGG COMPOUND:59865-13-3 "CAS Registry Number"; KEGG COMPOUND:C05086 "KEGG COMPOUND"; KEGG DRUG:D00184 "KEGG DRUG" xref_mesh: MESH:D016572 xref: Patent:US4117118 "Patent"; Reaxys:3647785 "Reaxys Registry Number"; Wikipedia:Ciclosporin "Wikipedia"
cyclosporin A
G
A1CF APOBEC1 complementation factor
decreases expression
EXP 10
52,559,169
52,645,435
RGD:6480464 CTD
G
A2M alpha-2-macroglobulin
decreases expression
EXP 12
9,220,304
9,268,558
RGD:6480464 CTD
G
AACS acetoacetyl-CoA synthetase
increases expression
EXP 12
125,549,925
125,627,871
RGD:6480464 CTD
G
AADAC arylacetamide deacetylase
decreases expression
EXP 3
151,531,861
151,546,276
RGD:6480464 CTD
G
AAED1 AhpC/TSA antioxidant enzyme domain containing 1
increases expression
EXP 9
99,403,533
99,417,599
RGD:6480464 CTD
G
AAMDC adipogenesis associated, Mth938 domain containing
decreases expression
EXP 11
77,532,208
77,583,398
RGD:6480464 CTD
G
AARS alanyl-tRNA synthetase
increases expression
EXP 16
70,286,297
70,323,412
RGD:6480464 CTD
G
AARSD1 alanyl-tRNA synthetase domain containing 1
increases expression
EXP 17
41,102,543
41,116,515
RGD:6480464 CTD
G
AASS aminoadipate-semialdehyde synthase
decreases expression
EXP 7
121,713,598
121,784,344
RGD:6480464 CTD
G
ABAT 4-aminobutyrate aminotransferase
decreases expression
EXP 16
8,768,444
8,878,432
RGD:6480464 CTD
G
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
decreases expression
EXP 9
107,543,283
107,690,527
RGD:6480464 CTD
G
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
multiple interactions
EXP 9
107,543,283
107,690,527
RGD:6480464 CTD
G
ABCA12 ATP-binding cassette, sub-family A (ABC1), member 12
increases expression
EXP 2
215,796,266
216,003,151
RGD:6480464 CTD
G
ABCA2 ATP-binding cassette, sub-family A (ABC1), member 2
decreases expression
EXP 9
139,901,686
139,923,374
RGD:6480464 CTD
G
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5
decreases expression
EXP 17
67,240,576
67,323,323
RGD:6480464 CTD
G
ABCA8 ATP-binding cassette, sub-family A (ABC1), member 8
decreases expression
EXP 17
66,863,430
66,951,533
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
affects export
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
affects response to substance
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
affects transport
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
affects response to substance
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
affects expression
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
increases transport
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
decreases activity
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
decreases expression
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
increases expression
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
ISO 7
87,133,179
87,342,639
RGD:6480464 CTD
G
ABCB10 ATP-binding cassette, sub-family B (MDR/TAP), member 10
decreases expression
EXP 1
229,652,329
229,694,442
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
decreases activity
EXP 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
decreases activity
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
affects localization
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
decreases activity
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
multiple interactions
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
multiple interactions
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
decreases expression
ISO 2
169,779,449
169,887,833
RGD:6480464 CTD
G
ABCB4 ATP-binding cassette, sub-family B (MDR/TAP), member 4
decreases expression
EXP 7
87,031,361
87,105,019
RGD:6480464 CTD
G
ABCB6 ATP-binding cassette, sub-family B (MDR/TAP), member 6
increases expression
EXP 2
220,074,488
220,083,712
RGD:6480464 CTD
G
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
multiple interactions
EXP 16
16,043,434
16,236,931
RGD:6480464 CTD
G
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
increases expression
EXP 16
16,043,434
16,236,931
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
decreases expression
EXP 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
decreases activity
EXP 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
multiple interactions
ISO 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
decreases expression
ISO 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
multiple interactions
ISO 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
decreases activity
ISO 10
101,542,463
101,611,662
RGD:6480464 CTD
G
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3
multiple interactions
EXP 17
48,712,218
48,769,063
RGD:6480464 CTD
G
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3
decreases expression
EXP 17
48,712,218
48,769,063
RGD:6480464 CTD
G
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4
increases expression
EXP 13
95,672,083
95,953,687
RGD:6480464 CTD
G
ABCC6 ATP-binding cassette, sub-family C (CFTR/MRP), member 6
decreases expression
EXP 16
16,243,422
16,317,328
RGD:6480464 CTD
G
ABCD2 ATP-binding cassette, sub-family D (ALD), member 2
decreases expression
EXP 12
39,945,022
40,013,843
RGD:6480464 CTD
G
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3
decreases expression
EXP 1
94,883,933
94,984,219
RGD:6480464 CTD
G
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1
increases expression
EXP 21
43,619,799
43,717,354
RGD:6480464 CTD
G
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2
multiple interactions
EXP 4
89,011,416
89,152,474
RGD:6480464 CTD
G
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2
decreases activity
EXP 4
89,011,416
89,152,474
RGD:6480464 CTD
G
ABCG5 ATP-binding cassette, sub-family G (WHITE), member 5
decreases expression
EXP 2
44,039,611
44,065,958
RGD:6480464 CTD
G
ABCG8 ATP-binding cassette, sub-family G (WHITE), member 8
decreases expression
EXP 2
44,066,103
44,105,605
RGD:6480464 CTD
G
ABHD14A abhydrolase domain containing 14A
decreases expression
EXP 3
52,009,042
52,015,216
RGD:6480464 CTD
G
ABHD14B abhydrolase domain containing 14B
decreases expression
EXP 3
52,002,526
52,008,646
RGD:6480464 CTD
G
ABHD2 abhydrolase domain containing 2
decreases expression
EXP 15
89,631,381
89,745,591
RGD:6480464 CTD
G
ABHD3 abhydrolase domain containing 3
increases expression
EXP 18
19,230,858
19,284,766
RGD:6480464 CTD
G
ABHD4 abhydrolase domain containing 4
increases expression
EXP 14
23,067,147
23,081,265
RGD:6480464 CTD
G
ABHD5 abhydrolase domain containing 5
increases expression
EXP 3
43,732,375
43,764,217
RGD:6480464 CTD
G
ABHD6 abhydrolase domain containing 6
decreases expression
EXP 3
58,223,259
58,280,461
RGD:6480464 CTD
G
ABI3BP ABI family, member 3 (NESH) binding protein
decreases expression
EXP 3
100,468,179
100,712,334
RGD:6480464 CTD
G
ABL2 v-abl Abelson murine leukemia viral oncogene homolog 2
increases expression
EXP 1
179,068,462
179,198,819
RGD:6480464 CTD
G
ABLIM3 actin binding LIM protein family, member 3
increases expression
EXP 5
148,521,054
148,639,999
RGD:6480464 CTD
G
ABP1 amiloride binding protein 1 (amine oxidase (copper-containing))
decreases expression
EXP 7
150,549,573
150,558,379
RGD:6480464 CTD
G
ABRACL ABRA C-terminal like
affects expression
EXP 6
139,349,819
139,364,439
RGD:6480464 CTD
G
ABTB2 ankyrin repeat and BTB (POZ) domain containing 2
increases expression
EXP 11
34,172,534
34,379,555
RGD:6480464 CTD
G
ACAA1 acetyl-CoA acyltransferase 1
decreases expression
EXP 3
38,164,201
38,178,733
RGD:6480464 CTD
G
ACAA2 acetyl-CoA acyltransferase 2
decreases expression
EXP 18
47,309,874
47,340,251
RGD:6480464 CTD
G
ACACA acetyl-CoA carboxylase alpha
decreases expression
EXP 17
35,441,927
35,766,902
RGD:6480464 CTD
G
ACACB acetyl-CoA carboxylase beta
decreases expression
EXP 12
109,577,202
109,706,031
RGD:6480464 CTD
G
ACAD11 acyl-CoA dehydrogenase family, member 11
decreases expression
EXP 3
132,276,982
132,378,975
RGD:6480464 CTD
G
ACAD8 acyl-CoA dehydrogenase family, member 8
decreases expression
EXP 11
134,123,434
134,135,749
RGD:6480464 CTD
G
ACADL acyl-CoA dehydrogenase, long chain
decreases expression
EXP 2
211,052,714
211,090,215
RGD:6480464 CTD
G
ACADL acyl-CoA dehydrogenase, long chain
decreases expression
ISO 2
211,052,714
211,090,215
RGD:6480464 CTD
G
ACADM acyl-CoA dehydrogenase, C-4 to C-12 straight chain
decreases expression
EXP 1
76,190,043
76,229,355
RGD:6480464 CTD
G
ACADSB acyl-CoA dehydrogenase, short/branched chain
decreases expression
EXP 10
124,768,429
124,817,806
RGD:6480464 CTD
G
ACAP2 ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
increases expression
EXP 3
194,995,465
195,163,817
RGD:6480464 CTD
G
ACAT1 acetyl-CoA acetyltransferase 1
decreases expression
EXP 11
107,992,258
108,018,895
RGD:6480464 CTD
G
ACAT2 acetyl-CoA acetyltransferase 2
decreases expression
EXP 6
160,182,989
160,200,087
RGD:6480464 CTD
G
ACBD3 acyl-CoA binding domain containing 3
increases expression
EXP 1
226,332,380
226,374,423
RGD:6480464 CTD
G
ACBD4 acyl-CoA binding domain containing 4
decreases expression
EXP 17
43,209,967
43,221,543
RGD:6480464 CTD
G
ACBD5 acyl-CoA binding domain containing 5
decreases expression
EXP 10
27,484,143
27,531,068
RGD:6480464 CTD
G
ACBD6 acyl-CoA binding domain containing 6
increases expression
EXP 1
180,257,352
180,472,022
RGD:6480464 CTD
G
ACD adrenocortical dysplasia homolog (mouse)
increases expression
EXP 16
67,691,415
67,694,718
RGD:6480464 CTD
G
ACHE acetylcholinesterase
increases expression
EXP 7
100,487,615
100,493,541
RGD:6480464 CTD
G
ACLY ATP citrate lyase
decreases expression
EXP 17
40,023,179
40,075,272
RGD:6480464 CTD
G
ACMSD aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP 2
135,596,186
135,659,604
RGD:6480464 CTD
G
ACN9 ACN9 homolog (S. cerevisiae)
decreases expression
EXP 7
96,745,905
96,811,075
RGD:6480464 CTD
G
ACO1 aconitase 1, soluble
decreases expression
EXP 9
32,384,601
32,450,834
RGD:6480464 CTD
G
ACOT12 acyl-CoA thioesterase 12
decreases expression
EXP 5
80,625,947
80,689,988
RGD:6480464 CTD
G
ACOT4 acyl-CoA thioesterase 4
decreases expression
EXP 14
74,058,410
74,062,470
RGD:6480464 CTD
G
ACOT9 acyl-CoA thioesterase 9
increases expression
EXP X
23,721,777
23,761,407
RGD:6480464 CTD
G
ACOX1 acyl-CoA oxidase 1, palmitoyl
decreases expression
EXP 17
73,937,588
73,975,515
RGD:6480464 CTD
G
ACOX2 acyl-CoA oxidase 2, branched chain
decreases expression
EXP 3
58,490,863
58,522,929
RGD:6480464 CTD
G
ACOX2 acyl-CoA oxidase 2, branched chain
decreases expression
ISO 3
58,490,863
58,522,929
RGD:6480464 CTD
G
ACP2 acid phosphatase 2, lysosomal
decreases expression
EXP 11
47,260,853
47,270,457
RGD:6480464 CTD
G
ACP5 acid phosphatase 5, tartrate resistant
multiple interactions
ISO 19
11,685,475
11,689,801
RGD:6480464 CTD
G
ACPL2 acid phosphatase-like 2
decreases expression
EXP 3
140,950,682
141,013,486
RGD:6480464 CTD
G
ACRC acidic repeat containing
increases expression
EXP X
70,797,874
70,833,433
RGD:6480464 CTD
G
ACSF2 acyl-CoA synthetase family member 2
decreases expression
EXP 17
48,503,519
48,552,200
RGD:6480464 CTD
G
ACSL1 acyl-CoA synthetase long-chain family member 1
decreases expression
EXP 4
185,676,749
185,747,215
RGD:6480464 CTD
G
ACSL3 acyl-CoA synthetase long-chain family member 3
increases expression
EXP 2
223,725,732
223,808,119
RGD:6480464 CTD
G
ACSL5 acyl-CoA synthetase long-chain family member 5
decreases expression
EXP 10
114,133,916
114,188,138
RGD:6480464 CTD
G
ACSM3 acyl-CoA synthetase medium-chain family member 3
decreases expression
EXP 16
20,775,312
20,808,479
RGD:6480464 CTD
G
ACSM5 acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP 16
20,420,856
20,452,290
RGD:6480464 CTD
G
ACSS2 acyl-CoA synthetase short-chain family member 2
decreases expression
EXP 20
33,462,766
33,515,769
RGD:6480464 CTD
G
ACSS3 acyl-CoA synthetase short-chain family member 3
decreases expression
EXP 12
81,471,809
81,649,582
RGD:6480464 CTD
G
ACTN4 actinin, alpha 4
decreases expression
EXP 19
39,138,267
39,221,171
RGD:6480464 CTD
G
ACTR3 ARP3 actin-related protein 3 homolog (yeast)
increases expression
EXP 2
114,647,537
114,716,167
RGD:6480464 CTD
G
ACVR1 activin A receptor, type I
increases expression
EXP 2
158,592,958
158,732,374
RGD:6480464 CTD
G
ACVR1C activin A receptor, type IC
decreases expression
EXP 2
158,383,279
158,485,399
RGD:6480464 CTD
G
ACY1 aminoacylase 1
decreases expression
EXP 3
52,017,300
52,023,218
RGD:6480464 CTD
G
ACY3 aspartoacylase (aminocyclase) 3
decreases expression
EXP 11
67,410,026
67,418,130
RGD:6480464 CTD
G
ACYP1 acylphosphatase 1, erythrocyte (common) type
affects expression
EXP 14
75,519,924
75,530,736
RGD:6480464 CTD
G
ADAL adenosine deaminase-like
decreases expression
EXP 15
43,622,872
43,646,096
RGD:6480464 CTD
G
ADAM17 ADAM metallopeptidase domain 17
increases expression
EXP 2
9,629,392
9,695,917
RGD:6480464 CTD
G
ADAMTS3 ADAM metallopeptidase with thrombospondin type 1 motif, 3
decreases expression
EXP 4
73,146,686
73,434,516
RGD:6480464 CTD
G
ADAMTSL4 ADAMTS-like 4
decreases expression
EXP 1
150,521,898
150,533,413
RGD:6480464 CTD
G
ADAT1 adenosine deaminase, tRNA-specific 1
decreases expression
EXP 16
75,632,247
75,657,221
RGD:6480464 CTD
G
ADCK3 aarF domain containing kinase 3
decreases expression
EXP 1
227,127,938
227,175,246
RGD:6480464 CTD
G
ADCY7 adenylate cyclase 7
increases expression
EXP 16
50,321,823
50,352,043
RGD:6480464 CTD
G
ADCY8 adenylate cyclase 8 (brain)
decreases expression
EXP 8
131,792,547
132,052,835
RGD:6480464 CTD
G
ADCY9 adenylate cyclase 9
decreases expression
EXP 16
4,012,650
4,166,186
RGD:6480464 CTD
G
ADD1 adducin 1 (alpha)
decreases expression
EXP 4
2,845,584
2,931,803
RGD:6480464 CTD
G
ADD3 adducin 3 (gamma)
decreases expression
EXP 10
111,765,726
111,895,323
RGD:6480464 CTD
G
ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide
decreases expression
EXP 4
100,197,523
100,212,185
RGD:6480464 CTD
G
ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide
decreases expression
EXP 4
100,227,527
100,242,572
RGD:6480464 CTD
G
ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
EXP 4
100,257,649
100,273,917
RGD:6480464 CTD
G
ADH4 alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
EXP 4
100,044,832
100,065,449
RGD:6480464 CTD
G
ADH6 alcohol dehydrogenase 6 (class V)
decreases expression
EXP 4
100,123,795
100,140,403
RGD:6480464 CTD
G
ADI1 acireductone dioxygenase 1
decreases expression
EXP 2
3,501,690
3,523,350
RGD:6480464 CTD
G
ADM adrenomedullin
increases expression
EXP 11
10,326,642
10,328,923
RGD:6480464 CTD
G
ADNP2 ADNP homeobox 2
increases expression
EXP 18
77,866,915
77,898,229
RGD:6480464 CTD
G
ADORA2B adenosine A2b receptor
increases expression
EXP 17
15,848,231
15,879,210
RGD:6480464 CTD
G
ADPRHL2 ADP-ribosylhydrolase like 2
increases expression
EXP 1
36,554,453
36,559,533
RGD:6480464 CTD
G
ADPRM ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent
increases expression
EXP 17
10,600,927
10,614,875
RGD:6480464 CTD
G
ADRA1A adrenoceptor alpha 1A
decreases expression
EXP 8
26,605,667
26,722,922
RGD:6480464 CTD
G
ADRB2 adrenoceptor beta 2, surface
decreases expression
EXP 5
148,206,156
148,208,197
RGD:6480464 CTD
G
ADRM1 adhesion regulating molecule 1
increases expression
EXP 20
60,878,027
60,883,918
RGD:6480464 CTD
G
ADSS adenylosuccinate synthase
increases expression
EXP 1
244,571,794
244,615,436
RGD:6480464 CTD
G
ADSSL1 adenylosuccinate synthase like 1
decreases expression
EXP 14
105,190,534
105,213,647
RGD:6480464 CTD
G
AEBP2 AE binding protein 2
increases expression
EXP 12
19,592,608
19,675,173
RGD:6480464 CTD
G
AEN apoptosis enhancing nuclease
increases expression
EXP 15
89,164,527
89,175,512
RGD:6480464 CTD
G
AFAP1 actin filament associated protein 1
increases expression
EXP 4
7,760,440
7,941,653
RGD:6480464 CTD
G
AFAP1L1 actin filament associated protein 1-like 1
increases expression
EXP 5
148,651,401
148,721,368
RGD:6480464 CTD
G
AFM afamin
decreases expression
EXP 4
74,347,462
74,369,718
RGD:6480464 CTD
G
AFP alpha-fetoprotein
increases expression
EXP 4
74,301,933
74,321,492
RGD:6480464 CTD
G
AGA aspartylglucosaminidase
increases expression
EXP 4
178,351,928
178,363,657
RGD:6480464 CTD
G
AGBL2 ATP/GTP binding protein-like 2
decreases expression
EXP 11
47,681,143
47,736,928
RGD:6480464 CTD
G
AGFG1 ArfGAP with FG repeats 1
increases expression
EXP 2
228,336,888
228,425,938
RGD:6480464 CTD
G
AGFG2 ArfGAP with FG repeats 2
decreases expression
EXP 7
100,136,834
100,165,843
RGD:6480464 CTD
G
AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
decreases expression
EXP 1
100,315,640
100,389,579
RGD:6480464 CTD
G
AGMAT agmatine ureohydrolase (agmatinase)
decreases expression
EXP 1
15,898,194
15,911,605
RGD:6480464 CTD
G
AGPAT1 1-acylglycerol-3-phosphate O-acyltransferase 1
decreases expression
EXP 6
32,135,983
32,145,888
RGD:6480464 CTD
G
AGPAT2 1-acylglycerol-3-phosphate O-acyltransferase 2
decreases expression
EXP 9
139,567,595
139,581,911
RGD:6480464 CTD
G
AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3
decreases expression
EXP 21
45,285,116
45,407,475
RGD:6480464 CTD
G
AGPAT5 1-acylglycerol-3-phosphate O-acyltransferase 5
increases expression
EXP 8
6,565,878
6,619,024
RGD:6480464 CTD
G
AGPAT9 1-acylglycerol-3-phosphate O-acyltransferase 9
increases expression
EXP 4
84,457,067
84,527,028
RGD:6480464 CTD
G
AGPS alkylglycerone phosphate synthase
increases expression
EXP 2
178,257,471
178,408,564
RGD:6480464 CTD
G
AGR2 anterior gradient 2 homolog (Xenopus laevis)
increases expression
EXP 7
16,832,264
16,844,738
RGD:6480464 CTD
G
AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
decreases expression
EXP 1
230,838,269
230,850,336
RGD:6480464 CTD
G
AGTPBP1 ATP/GTP binding protein 1
increases expression
EXP 9
88,161,454
88,356,944
RGD:6480464 CTD
G
AGTR1 angiotensin II receptor, type 1
decreases expression
EXP 3
148,415,658
148,460,790
RGD:6480464 CTD
G
AGTRAP angiotensin II receptor-associated protein
increases expression
EXP 1
11,796,142
11,810,828
RGD:6480464 CTD
G
AGXT alanine-glyoxylate aminotransferase
decreases expression
EXP 2
241,808,162
241,818,536
RGD:6480464 CTD
G
AGXT2 alanine--glyoxylate aminotransferase 2
decreases expression
EXP 5
34,998,206
35,048,240
RGD:6480464 CTD
G
AGXT2L1 alanine-glyoxylate aminotransferase 2-like 1
decreases expression
EXP 4
109,663,196
109,684,235
RGD:6480464 CTD
G
AHI1 Abelson helper integration site 1
increases expression
EXP 6
135,605,110
135,818,903
RGD:6480464 CTD
G
AHSA1 AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
increases expression
EXP 14
77,924,373
77,935,815
RGD:6480464 CTD
G
AHSG alpha-2-HS-glycoprotein
decreases expression
EXP 3
186,330,850
186,339,107
RGD:6480464 CTD
G
AIFM1 apoptosis-inducing factor, mitochondrion-associated, 1
decreases expression
EXP X
129,263,337
129,299,861
RGD:6480464 CTD
G
AIFM2 apoptosis-inducing factor, mitochondrion-associated, 2
increases expression
EXP 10
71,872,023
71,892,690
RGD:6480464 CTD
G
AIG1 androgen-induced 1
decreases expression
EXP 6
143,382,023
143,661,441
RGD:6480464 CTD
G
AIM1L absent in melanoma 1-like
increases expression
EXP 1
26,648,350
26,680,621
RGD:6480464 CTD
G
AIMP2 aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
increases expression
EXP 7
6,048,882
6,063,465
RGD:6480464 CTD
G
AJUBA ajuba LIM protein
decreases expression
EXP 14
23,440,409
23,451,851
RGD:6480464 CTD
G
AK2 adenylate kinase 2
decreases expression
EXP 1
33,473,541
33,502,512
RGD:6480464 CTD
G
AKAP1 A kinase (PRKA) anchor protein 1
decreases expression
EXP 17
55,162,553
55,198,710
RGD:6480464 CTD
G
AKAP12 A kinase (PRKA) anchor protein 12
increases expression
EXP 6
151,561,134
151,679,694
RGD:6480464 CTD
G
AKD2 adenylate kinase domain containing 2
increases expression
EXP
RGD:6480464 CTD
G
AKIP1 A kinase (PRKA) interacting protein 1
decreases expression
EXP 11
8,932,701
8,941,626
RGD:6480464 CTD
G
AKIRIN2 akirin 2
increases expression
EXP 6
88,384,578
88,411,985
RGD:6480464 CTD
G
AKNA AT-hook transcription factor
increases expression
EXP 9
117,096,429
117,156,685
RGD:6480464 CTD
G
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase)
increases expression
EXP 7
134,127,107
134,143,888
RGD:6480464 CTD
G
AKR1C4 aldo-keto reductase family 1, member C4
decreases expression
EXP 10
5,238,798
5,260,910
RGD:6480464 CTD
G
AKR1D1 aldo-keto reductase family 1, member D1
decreases expression
EXP 7
137,761,178
137,803,050
RGD:6480464 CTD
G
AKR7A2 aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)
decreases expression
EXP 1
19,629,202
19,638,640
RGD:6480464 CTD
G
AKR7A3 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)
decreases expression
EXP 1
19,609,057
19,615,280
RGD:6480464 CTD
G
AKT1 v-akt murine thymoma viral oncogene homolog 1
multiple interactions
ISO 14
105,235,686
105,262,080
RGD:6480464 CTD
G
AKT1 v-akt murine thymoma viral oncogene homolog 1
decreases expression
EXP 14
105,235,686
105,262,080
RGD:6480464 CTD
G
AKT3 v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
increases expression
EXP 1
243,651,535
244,006,886
RGD:6480464 CTD
G
ALAD aminolevulinate dehydratase
decreases expression
EXP 9
116,148,592
116,163,618
RGD:6480464 CTD
G
ALB albumin
decreases expression
EXP 4
74,269,972
74,287,129
RGD:6480464 CTD
G
ALB albumin
increases expression
EXP 4
74,269,972
74,287,129
RGD:6480464 CTD
G
ALDH18A1 aldehyde dehydrogenase 18 family, member A1
decreases expression
EXP 10
97,365,686
97,416,567
RGD:6480464 CTD
G
ALDH1A1 aldehyde dehydrogenase 1 family, member A1
decreases expression
EXP 9
75,515,578
75,568,233
RGD:6480464 CTD
G
ALDH1B1 aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP 9
38,392,661
38,398,662
RGD:6480464 CTD
G
ALDH1L1 aldehyde dehydrogenase 1 family, member L1
decreases expression
EXP 3
125,822,404
125,900,029
RGD:6480464 CTD
G
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial)
decreases expression
EXP 12
112,204,691
112,247,789
RGD:6480464 CTD
G
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial)
increases expression
EXP 12
112,204,691
112,247,789
RGD:6480464 CTD
G
ALDH3A1 aldehyde dehydrogenase 3 family, member A1
decreases expression
EXP 17
19,641,297
19,651,746
RGD:6480464 CTD
G
ALDH3A2 aldehyde dehydrogenase 3 family, member A2
decreases expression
EXP 17
19,552,064
19,580,908
RGD:6480464 CTD
G
ALDH4A1 aldehyde dehydrogenase 4 family, member A1
decreases expression
EXP 1
19,197,924
19,229,293
RGD:6480464 CTD
G
ALDH5A1 aldehyde dehydrogenase 5 family, member A1
decreases expression
EXP 6
24,495,197
24,537,435
RGD:6480464 CTD
G
ALDH6A1 aldehyde dehydrogenase 6 family, member A1
decreases expression
EXP 14
74,526,869
74,551,196
RGD:6480464 CTD
G
ALDH7A1 aldehyde dehydrogenase 7 family, member A1
decreases expression
EXP 5
125,877,533
125,931,082
RGD:6480464 CTD
G
ALDH8A1 aldehyde dehydrogenase 8 family, member A1
decreases expression
EXP 6
135,238,528
135,271,260
RGD:6480464 CTD
G
ALDH9A1 aldehyde dehydrogenase 9 family, member A1
decreases expression
EXP 1
165,631,449
165,667,900
RGD:6480464 CTD
G
ALDOA aldolase A, fructose-bisphosphate
decreases expression
EXP 16
30,064,411
30,081,741
RGD:6480464 CTD
G
ALDOB aldolase B, fructose-bisphosphate
decreases expression
EXP 9
104,182,842
104,198,062
RGD:6480464 CTD
G
ALDOC aldolase C, fructose-bisphosphate
decreases expression
EXP 17
26,900,133
26,903,951
RGD:6480464 CTD
G
ALG2 ALG2, alpha-1,3/1,6-mannosyltransferase
increases expression
EXP 9
101,978,707
101,984,246
RGD:6480464 CTD
G
ALG5 ALG5, dolichyl-phosphate beta-glucosyltransferase
increases expression
EXP 13
37,523,907
37,573,504
RGD:6480464 CTD
G
ALG6 ALG6, alpha-1,3-glucosyltransferase
decreases expression
EXP 1
63,833,261
63,904,233
RGD:6480464 CTD
G
ALG8 ALG8, alpha-1,3-glucosyltransferase
decreases expression
EXP 11
77,811,988
77,850,699
RGD:6480464 CTD
G
ALKBH2 alkB, alkylation repair homolog 2 (E. coli)
decreases expression
EXP 12
109,525,993
109,531,293
RGD:6480464 CTD
G
ALKBH3 alkB, alkylation repair homolog 3 (E. coli)
increases expression
EXP 11
43,902,357
43,941,825
RGD:6480464 CTD
G
ALMS1 Alstrom syndrome 1
increases expression
EXP 2
73,612,886
73,837,046
RGD:6480464 CTD
G
ALOXE3 arachidonate lipoxygenase 3
increases expression
EXP 17
7,999,218
8,022,234
RGD:6480464 CTD
G
ALPK2 alpha-kinase 2
increases expression
EXP 18
56,148,479
56,296,189
RGD:6480464 CTD
G
ALPL alkaline phosphatase, liver/bone/kidney
decreases expression
EXP 1
21,835,858
21,904,905
RGD:6480464 CTD
G
AMACR alpha-methylacyl-CoA racemase
decreases expression
EXP 5
33,987,091
34,008,220
RGD:6480464 CTD
G
AMBP alpha-1-microglobulin/bikunin precursor
decreases expression
EXP 9
116,822,407
116,840,752
RGD:6480464 CTD
G
AMDHD1 amidohydrolase domain containing 1
decreases expression
EXP 12
96,337,071
96,362,370
RGD:6480464 CTD
G
AMIGO2 adhesion molecule with Ig-like domain 2
decreases expression
EXP 12
47,469,490
47,473,734
RGD:6480464 CTD
G
AMMECR1L AMMECR1-like
increases expression
EXP 2
128,619,204
128,643,514
RGD:6480464 CTD
G
AMPD3 adenosine monophosphate deaminase 3
increases expression
EXP 11
10,471,868
10,529,126
RGD:6480464 CTD
G
AMPH amphiphysin
decreases expression
EXP 7
38,423,297
38,671,167
RGD:6480464 CTD
G
AMZ2 archaelysin family metallopeptidase 2
increases expression
EXP 17
66,244,145
66,253,305
RGD:6480464 CTD
G
AMZ2P1 archaelysin family metallopeptidase 2 pseudogene 1
increases expression
EXP 17
62,962,668
62,971,703
RGD:6480464 CTD
G
ANAPC15 anaphase promoting complex subunit 15
decreases expression
EXP 11
71,820,633
71,823,822
RGD:6480464 CTD
G
ANG angiogenin, ribonuclease, RNase A family, 5
affects expression
EXP 14
21,152,336
21,162,345
RGD:6480464 CTD
G
ANGPT1 angiopoietin 1
decreases expression
EXP 8
108,261,710
108,510,254
RGD:6480464 CTD
G
ANGPTL3 angiopoietin-like 3
decreases expression
EXP 1
63,063,187
63,071,180
RGD:6480464 CTD
G
ANK2 ankyrin 2, neuronal
increases expression
EXP 4
113,739,239
114,304,896
RGD:6480464 CTD
G
ANK3 ankyrin 3, node of Ranvier (ankyrin G)
decreases expression
EXP 10
61,786,056
62,493,284
RGD:6480464 CTD
G
ANKEF1 ankyrin repeat and EF-hand domain containing 1
increases expression
EXP 20
10,015,697
10,037,407
RGD:6480464 CTD
G
ANKHD1 ankyrin repeat and KH domain containing 1
increases expression
EXP 5
139,781,399
139,919,441
RGD:6480464 CTD
G
ANKIB1 ankyrin repeat and IBR domain containing 1
increases expression
EXP 7
91,875,548
92,030,698
RGD:6480464 CTD
G
ANKLE2 ankyrin repeat and LEM domain containing 2
increases expression
EXP 12
133,302,254
133,338,451
RGD:6480464 CTD
G
ANKMY2 ankyrin repeat and MYND domain containing 2
increases expression
EXP 7
16,639,401
16,685,442
RGD:6480464 CTD
G
ANKRD11 ankyrin repeat domain 11
increases expression
EXP 16
89,334,029
89,556,969
RGD:6480464 CTD
G
ANKRD12 ankyrin repeat domain 12
increases expression
EXP 18
9,136,751
9,285,983
RGD:6480464 CTD
G
ANKRD13C ankyrin repeat domain 13C
increases expression
EXP 1
70,724,685
70,820,417
RGD:6480464 CTD
G
ANKRD27 ankyrin repeat domain 27 (VPS9 domain)
increases expression
EXP 19
33,087,907
33,166,102
RGD:6480464 CTD
G
ANKRD28 ankyrin repeat domain 28
increases expression
EXP 3
15,708,743
15,901,053
RGD:6480464 CTD
G
ANKRD29 ankyrin repeat domain 29
decreases expression
EXP 18
21,179,977
21,242,849
RGD:6480464 CTD
G
ANKRD30A ankyrin repeat domain 30A
decreases expression
EXP 10
37,414,785
37,521,495
RGD:6480464 CTD
G
ANKRD32 ankyrin repeat domain 32
decreases expression
EXP 5
93,954,391
94,031,573
RGD:6480464 CTD
G
ANKRD37 ankyrin repeat domain 37
affects expression
EXP 4
186,317,840
186,321,390
RGD:6480464 CTD
G
ANKRD39 ankyrin repeat domain 39
decreases expression
EXP 2
97,513,722
97,523,756
RGD:6480464 CTD
G
ANKRD46 ankyrin repeat domain 46
decreases expression
EXP 8
101,521,980
101,572,014
RGD:6480464 CTD
G
ANKS4B ankyrin repeat and sterile alpha motif domain containing 4B
decreases expression
EXP 16
21,245,016
21,263,750
RGD:6480464 CTD
G
ANLN anillin, actin binding protein
decreases expression
EXP 7
36,429,432
36,493,400
RGD:6480464 CTD
G
ANO10 anoctamin 10
increases expression
EXP 3
43,407,818
43,663,560
RGD:6480464 CTD
G
ANP32A acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
decreases expression
EXP 15
69,070,874
69,113,261
RGD:6480464 CTD
G
ANP32B acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
increases expression
EXP 9
100,745,489
100,778,225
RGD:6480464 CTD
G
ANP32E acidic (leucine-rich) nuclear phosphoprotein 32 family, member E
increases expression
EXP 1
150,190,717
150,208,504
RGD:6480464 CTD
G
ANPEP alanyl (membrane) aminopeptidase
decreases expression
EXP 15
90,328,126
90,358,072
RGD:6480464 CTD
G
ANPEP alanyl (membrane) aminopeptidase
increases secretion
ISO 15
90,328,126
90,358,072
RGD:6480464 CTD
G
ANTXR2 anthrax toxin receptor 2
affects expression
EXP 4
80,822,771
80,994,477
RGD:6480464 CTD
G
ANXA1 annexin A1
increases expression
EXP 9
75,766,781
75,785,307
RGD:6480464 CTD
G
ANXA10 annexin A10
decreases expression
EXP 4
169,013,688
169,108,893
RGD:6480464 CTD
G
ANXA11 annexin A11
decreases expression
EXP 10
81,914,880
81,965,328
RGD:6480464 CTD
G
ANXA2P1 annexin A2 pseudogene 1
increases expression
EXP 4
154,228,621
154,229,963
RGD:6480464 CTD
G
ANXA2P2 annexin A2 pseudogene 2
increases expression
EXP 9
33,624,223
33,625,532
RGD:6480464 CTD
G
ANXA3 annexin A3
increases expression
EXP 4
79,472,742
79,531,605
RGD:6480464 CTD
G
ANXA5 annexin A5
increases expression
EXP 4
122,589,152
122,618,147
RGD:6480464 CTD
G
ANXA9 annexin A9
decreases expression
EXP 1
150,954,499
150,968,114
RGD:6480464 CTD
G
AOX1 aldehyde oxidase 1
decreases expression
EXP 2
201,450,731
201,536,218
RGD:6480464 CTD
G
AP1AR adaptor-related protein complex 1 associated regulatory protein
increases expression
EXP 4
113,152,895
113,191,211
RGD:6480464 CTD
G
AP1B1 adaptor-related protein complex 1, beta 1 subunit
decreases expression
EXP 22
29,723,669
29,784,572
RGD:6480464 CTD
G
AP1M1 adaptor-related protein complex 1, mu 1 subunit
decreases expression
EXP 19
16,308,665
16,346,156
RGD:6480464 CTD
G
AP1M2 adaptor-related protein complex 1, mu 2 subunit
decreases expression
EXP 19
10,683,347
10,697,991
RGD:6480464 CTD
G
AP1S1 adaptor-related protein complex 1, sigma 1 subunit
decreases expression
EXP 7
100,797,686
100,804,557
RGD:6480464 CTD
G
AP1S3 adaptor-related protein complex 1, sigma 3 subunit
decreases expression
EXP 2
224,620,047
224,702,319
RGD:6480464 CTD
G
AP3D1 adaptor-related protein complex 3, delta 1 subunit
increases expression
EXP 19
2,100,987
2,151,556
RGD:6480464 CTD
G
AP3M2 adaptor-related protein complex 3, mu 2 subunit
increases expression
EXP 8
42,010,464
42,028,701
RGD:6480464 CTD
G
AP4B1 adaptor-related protein complex 4, beta 1 subunit
increases expression
EXP 1
114,437,370
114,447,741
RGD:6480464 CTD
G
APBA3 amyloid beta (A4) precursor protein-binding, family A, member 3
increases expression
EXP 19
3,750,771
3,761,673
RGD:6480464 CTD
G
APBB1IP amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
decreases expression
EXP 10
26,727,266
26,856,732
RGD:6480464 CTD
G
APCDD1L adenomatosis polyposis coli down-regulated 1-like
increases expression
EXP 20
57,034,426
57,089,949
RGD:6480464 CTD
G
APCS amyloid P component, serum
decreases expression
EXP 1
159,557,616
159,558,661
RGD:6480464 CTD
G
APEH N-acylaminoacyl-peptide hydrolase
decreases expression
EXP 3
49,711,435
49,720,934
RGD:6480464 CTD
G
APITD1 apoptosis-inducing, TAF9-like domain 1
decreases expression
EXP 1
10,490,159
10,502,872
RGD:6480464 CTD
G
APOA1 apolipoprotein A-I
decreases expression
EXP 11
116,706,469
116,708,338
RGD:6480464 CTD
G
APOA1 apolipoprotein A-I
increases expression
EXP 11
116,706,469
116,708,338
RGD:6480464 CTD
G
APOA1BP apolipoprotein A-I binding protein
decreases expression
EXP 1
156,561,558
156,564,091
RGD:6480464 CTD
G
APOA2 apolipoprotein A-II
decreases expression
EXP 1
161,192,083
161,193,418
RGD:6480464 CTD
G
APOA5 apolipoprotein A-V
decreases expression
EXP 11
116,660,086
116,663,136
RGD:6480464 CTD
G
APOB apolipoprotein B (including Ag(x) antigen)
decreases expression
EXP 2
21,224,301
21,266,945
RGD:6480464 CTD
G
APOB apolipoprotein B (including Ag(x) antigen)
decreases expression
ISO 2
21,224,301
21,266,945
RGD:6480464 CTD
G
APOBEC3B apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
decreases expression
EXP 22
39,378,404
39,388,784
RGD:6480464 CTD
G
APOC1 apolipoprotein C-I
decreases expression
EXP 19
45,417,921
45,422,606
RGD:6480464 CTD
G
APOC3 apolipoprotein C-III
decreases expression
EXP 11
116,700,624
116,703,787
RGD:6480464 CTD
G
APOE apolipoprotein E
decreases expression
EXP 19
45,409,039
45,412,650
RGD:6480464 CTD
G
APOH apolipoprotein H (beta-2-glycoprotein I)
decreases expression
EXP 17
64,208,147
64,225,556
RGD:6480464 CTD
G
APOL1 apolipoprotein L, 1
increases expression
EXP 22
36,649,117
36,663,577
RGD:6480464 CTD
G
APOL3 apolipoprotein L, 3
decreases expression
ISO 22
36,536,371
36,562,225
RGD:6480464 CTD
G
APOM apolipoprotein M
decreases expression
EXP 6
31,620,187
31,625,987
RGD:6480464 CTD
G
APOPT1 apoptogenic 1, mitochondrial
increases expression
EXP 14
104,029,299
104,057,236
RGD:6480464 CTD
G
APPL2 adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
decreases expression
EXP 12
105,567,075
105,630,008
RGD:6480464 CTD
G
AQP11 aquaporin 11
decreases expression
EXP 11
77,300,680
77,321,401
RGD:6480464 CTD
G
AQP3 aquaporin 3 (Gill blood group)
decreases expression
EXP 9
33,441,152
33,447,631
RGD:6480464 CTD
G
AQP9 aquaporin 9
decreases expression
EXP 15
58,430,408
58,478,110
RGD:6480464 CTD
G
AQPEP laeverin
increases expression
EXP 5
115,298,151
115,363,299
RGD:6480464 CTD
G
AR androgen receptor
decreases expression
EXP X
66,763,874
66,950,461
RGD:6480464 CTD
G
ARAP2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
increases expression
EXP 4
36,067,620
36,245,979
RGD:6480464 CTD
G
ARCN1 archain 1
increases expression
EXP 11
118,443,102
118,473,748
RGD:6480464 CTD
G
ARF1 ADP-ribosylation factor 1
increases expression
EXP 1
228,270,361
228,286,913
RGD:6480464 CTD
G
ARF4 ADP-ribosylation factor 4
increases expression
EXP 3
57,557,090
57,583,215
RGD:6480464 CTD
G
ARFGAP3 ADP-ribosylation factor GTPase activating protein 3
increases expression
EXP 22
43,192,532
43,253,408
RGD:6480464 CTD
G
ARFGEF2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
increases expression
EXP 20
47,538,275
47,653,230
RGD:6480464 CTD
G
ARFIP2 ADP-ribosylation factor interacting protein 2
increases expression
EXP 11
6,495,913
6,502,709
RGD:6480464 CTD
G
ARG1 arginase, liver
decreases expression
EXP 6
131,894,344
131,905,472
RGD:6480464 CTD
G
ARG2 arginase, type II
increases expression
EXP 14
68,086,579
68,118,437
RGD:6480464 CTD
G
ARHGAP21 Rho GTPase activating protein 21
increases expression
EXP 10
24,872,538
25,012,597
RGD:6480464 CTD
G
ARHGAP26 Rho GTPase activating protein 26
increases expression
EXP 5
142,150,292
142,608,572
RGD:6480464 CTD
G
ARHGAP5-AS1 ARHGAP5 antisense RNA 1 (head to head)
decreases expression
EXP 14
32,544,625
32,545,905
RGD:6480464 CTD
G
ARHGEF10L Rho guanine nucleotide exchange factor (GEF) 10-like
decreases expression
EXP 1
17,866,330
18,024,370
RGD:6480464 CTD
G
ARHGEF18 Rho/Rac guanine nucleotide exchange factor (GEF) 18
decreases expression
EXP 19
7,459,999
7,537,371
RGD:6480464 CTD
G
ARHGEF2 Rho/Rac guanine nucleotide exchange factor (GEF) 2
increases expression
EXP 1
155,916,630
155,948,336
RGD:6480464 CTD
G
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3
increases expression
EXP 3
56,761,446
57,113,336
RGD:6480464 CTD
G
ARHGEF40 Rho guanine nucleotide exchange factor (GEF) 40
decreases expression
EXP 14
21,538,527
21,558,036
RGD:6480464 CTD
G
ARHGEF5 Rho guanine nucleotide exchange factor (GEF) 5
increases expression
EXP 7
144,052,489
144,077,725
RGD:6480464 CTD
G
ARHGEF9 Cdc42 guanine nucleotide exchange factor (GEF) 9
decreases expression
EXP X
62,854,848
63,005,426
RGD:6480464 CTD
G
ARIH1 ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila)
increases expression
EXP 15
72,766,667
72,878,896
RGD:6480464 CTD
G
ARIH2 ariadne homolog 2 (Drosophila)
increases expression
EXP 3
48,956,281
49,022,974
RGD:6480464 CTD
G
ARL1 ADP-ribosylation factor-like 1
increases expression
EXP 12
101,786,903
101,801,572
RGD:6480464 CTD
G
ARL15 ADP-ribosylation factor-like 15
decreases expression
EXP 5
53,180,614
53,606,403
RGD:6480464 CTD
G
ARL4C ADP-ribosylation factor-like 4C
increases expression
EXP 2
235,401,685
235,405,693
RGD:6480464 CTD
G
ARL5A ADP-ribosylation factor-like 5A
decreases expression
EXP 2
152,657,480
152,685,009
RGD:6480464 CTD
G
ARL5B ADP-ribosylation factor-like 5B
increases expression
EXP 10
18,948,313
18,966,940
RGD:6480464 CTD
G
ARL6 ADP-ribosylation factor-like 6
increases expression
EXP 3
97,483,595
97,517,373
RGD:6480464 CTD
G
ARL6IP5 ADP-ribosylation-like factor 6 interacting protein 5
decreases expression
EXP 3
69,134,090
69,155,239
RGD:6480464 CTD
G
ARL6IP6 ADP-ribosylation-like factor 6 interacting protein 6
increases expression
EXP 2
153,574,407
153,617,767
RGD:6480464 CTD
G
ARL8A ADP-ribosylation factor-like 8A
increases expression
EXP 1
202,102,532
202,113,871
RGD:6480464 CTD
G
ARL8B ADP-ribosylation factor-like 8B
increases expression
EXP 3
5,163,930
5,222,601
RGD:6480464 CTD
G
ARMCX1 armadillo repeat containing, X-linked 1
increases expression
EXP X
100,805,514
100,809,683
RGD:6480464 CTD
G
ARMCX3 armadillo repeat containing, X-linked 3
increases expression
EXP X
100,878,120
100,882,831
RGD:6480464 CTD
G
ARMCX5 armadillo repeat containing, X-linked 5
increases expression
EXP X
101,854,096
101,859,087
RGD:6480464 CTD
G
ARNT2 aryl-hydrocarbon receptor nuclear translocator 2
increases expression
EXP 15
80,696,692
80,890,278
RGD:6480464 CTD
G
ARNTL2 aryl hydrocarbon receptor nuclear translocator-like 2
increases expression
EXP 12
27,485,787
27,578,746
RGD:6480464 CTD
G
ARPC1B actin related protein 2/3 complex, subunit 1B, 41kDa
increases expression
EXP 7
98,972,298
98,992,424
RGD:6480464 CTD
G
ARPC2 actin related protein 2/3 complex, subunit 2, 34kDa
increases expression
EXP 2
219,081,874
219,119,071
RGD:6480464 CTD
G
ARRDC2 arrestin domain containing 2
decreases expression
EXP 19
18,111,944
18,124,911
RGD:6480464 CTD
G
ARRDC4 arrestin domain containing 4
increases expression
EXP 15
98,503,933
98,517,068
RGD:6480464 CTD
G
ARSD arylsulfatase D
decreases expression
EXP X
2,822,011
2,847,416
RGD:6480464 CTD
G
ARSE arylsulfatase E (chondrodysplasia punctata 1)
decreases expression
EXP X
2,852,673
2,882,494
RGD:6480464 CTD
G
ARSK arylsulfatase family, member K
decreases expression
EXP 5
94,890,825
94,940,806
RGD:6480464 CTD
G
ART3 ADP-ribosyltransferase 3
decreases expression
EXP 4
76,932,333
77,033,955
RGD:6480464 CTD
G
ART4 ADP-ribosyltransferase 4 (Dombrock blood group)
decreases expression
EXP 12
14,982,245
14,996,413
RGD:6480464 CTD
G
AS3MT arsenic (+3 oxidation state) methyltransferase
decreases expression
EXP 10
104,629,210
104,661,656
RGD:6480464 CTD
G
ASAP1-IT1 ASAP1 intronic transcript 1 (non-protein coding)
increases expression
EXP 8
131,307,601
131,308,779
RGD:6480464 CTD
G
ASB13 ankyrin repeat and SOCS box containing 13
decreases expression
EXP 10
5,680,820
5,708,558
RGD:6480464 CTD
G
ASB16-AS1 ASB16 antisense RNA 1
affects expression
EXP 17
42,253,341
42,264,085
RGD:6480464 CTD
G
ASB3 ankyrin repeat and SOCS box containing 3
increases expression
EXP 2
53,897,117
54,014,146
RGD:6480464 CTD
G
ASB9 ankyrin repeat and SOCS box containing 9
decreases expression
EXP X
15,262,109
15,288,589
RGD:6480464 CTD
G
ASCC3 activating signal cointegrator 1 complex subunit 3
increases expression
EXP 6
100,956,608
101,329,224
RGD:6480464 CTD
G
ASF1A ASF1 anti-silencing function 1 homolog A (S. cerevisiae)
increases expression
EXP 6
119,215,241
119,230,336
RGD:6480464 CTD
G
ASF1B ASF1 anti-silencing function 1 homolog B (S. cerevisiae)
decreases expression
EXP 19
14,230,321
14,247,440
RGD:6480464 CTD
G
ASGR1 asialoglycoprotein receptor 1
decreases expression
EXP 17
7,076,750
7,082,883
RGD:6480464 CTD
G
ASGR2 asialoglycoprotein receptor 2
decreases expression
EXP 17
7,004,641
7,018,130
RGD:6480464 CTD
G
ASL argininosuccinate lyase
decreases expression
EXP 7
65,540,776
65,558,330
RGD:6480464 CTD
G
ASNS asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP 7
97,481,429
97,501,854
RGD:6480464 CTD
G
ASPA aspartoacylase
decreases expression
EXP 17
3,377,404
3,402,700
RGD:6480464 CTD
G
ASPH aspartate beta-hydroxylase
increases expression
EXP 8
62,413,115
62,627,199
RGD:6480464 CTD
G
ASPHD2 aspartate beta-hydroxylase domain containing 2
increases expression
EXP 22
26,825,280
26,840,978
RGD:6480464 CTD
G
ASPM asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
decreases expression
EXP 1
197,053,257
197,115,824
RGD:6480464 CTD
G
ASRGL1 asparaginase like 1
decreases expression
EXP 11
62,104,774
62,160,887
RGD:6480464 CTD
G
ASS1 argininosuccinate synthase 1
decreases expression
EXP 9
133,320,094
133,376,661
RGD:6480464 CTD
G
ASUN asunder spermatogenesis regulator
increases expression
EXP 12
27,058,112
27,091,254
RGD:6480464 CTD
G
ATAD2 ATPase family, AAA domain containing 2
decreases expression
EXP 8
124,332,090
124,408,705
RGD:6480464 CTD
G
ATF2 activating transcription factor 2
increases phosphorylation
ISO 2
175,936,978
176,032,934
RGD:6480464 CTD
G
ATF2 activating transcription factor 2
increases expression
EXP 2
175,936,978
176,032,934
RGD:6480464 CTD
G
ATF3 activating transcription factor 3
increases expression
EXP 1
212,738,676
212,794,119
RGD:6480464 CTD
G
ATF6 activating transcription factor 6
increases expression
EXP 1
161,736,034
161,933,860
RGD:6480464 CTD
G
ATG10 autophagy related 10
decreases expression
EXP 5
81,267,844
81,551,213
RGD:6480464 CTD
G
ATG13 autophagy related 13
increases expression
EXP 11
46,638,826
46,697,569
RGD:6480464 CTD
G
ATG3 autophagy related 3
increases expression
EXP 3
112,251,359
112,280,485
RGD:6480464 CTD
G
ATL1 atlastin GTPase 1
decreases expression
EXP 14
50,999,800
51,099,786
RGD:6480464 CTD
G
ATL3 atlastin GTPase 3
increases expression
EXP 11
63,396,437
63,439,083
RGD:6480464 CTD
G
ATOX1 ATX1 antioxidant protein 1 homolog (yeast)
decreases expression
EXP 5
151,122,383
151,138,210
RGD:6480464 CTD
G
ATP10D ATPase, class V, type 10D
increases expression
EXP 4
47,487,410
47,595,503
RGD:6480464 CTD
G
ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide
decreases expression
EXP 1
116,915,795
116,947,396
RGD:6480464 CTD
G
ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
decreases expression
EXP 12
110,719,032
110,788,898
RGD:6480464 CTD
G
ATP2B1 ATPase, Ca++ transporting, plasma membrane 1
increases expression
EXP 12
89,981,826
90,049,844
RGD:6480464 CTD
G
ATP5B ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
decreases expression
EXP 12
57,031,959
57,039,852
RGD:6480464 CTD
G
ATP5C1 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
decreases expression
EXP 10
7,830,093
7,849,764
RGD:6480464 CTD
G
ATP5D ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit
decreases expression
EXP 19
1,241,749
1,244,824
RGD:6480464 CTD
G
ATP5F1 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
decreases expression
EXP 1
111,991,743
112,004,540
RGD:6480464 CTD
G
ATP5G1 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)
decreases expression
EXP 17
46,970,148
46,973,233
RGD:6480464 CTD
G
ATP5G3 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)
decreases expression
EXP 2
176,040,986
176,046,490
RGD:6480464 CTD
G
ATP5I ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E
decreases expression
EXP 4
666,225
668,127
RGD:6480464 CTD
G
ATP5J2 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2
decreases expression
EXP 7
99,055,784
99,063,824
RGD:6480464 CTD
G
ATP5L ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G
decreases expression
EXP 11
118,272,104
118,280,562
RGD:6480464 CTD
G
ATP6V0A1 ATPase, H+ transporting, lysosomal V0 subunit a1
decreases expression
EXP 17
40,610,862
40,674,597
RGD:6480464 CTD
G
ATP6V0A2 ATPase, H+ transporting, lysosomal V0 subunit a2
increases expression
EXP 12
124,196,865
124,246,302
RGD:6480464 CTD
G
ATP6V0B ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b
increases expression
EXP 1
44,440,602
44,443,972
RGD:6480464 CTD
G
ATP6V0E2 ATPase, H+ transporting V0 subunit e2
decreases expression
EXP 7
149,570,057
149,577,787
RGD:6480464 CTD
G
ATP6V1A ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A
decreases expression
EXP 3
113,465,866
113,530,905
RGD:6480464 CTD
G
ATP6V1E2 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2
increases expression
EXP 2
46,738,986
46,747,096
RGD:6480464 CTD
G
ATP6V1G1 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1
increases expression
EXP 9
117,349,994
117,361,152
RGD:6480464 CTD
G
ATP7B ATPase, Cu++ transporting, beta polypeptide
decreases expression
EXP 13
52,506,805
52,585,630
RGD:6480464 CTD
G
ATP8A1 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1
increases expression
EXP 4
42,410,390
42,659,122
RGD:6480464 CTD
G
ATP8B1 ATPase, aminophospholipid transporter, class I, type 8B, member 1
decreases expression
EXP 18
55,313,658
55,470,327
RGD:6480464 CTD
G
ATP8B2 ATPase, aminophospholipid transporter, class I, type 8B, member 2
increases expression
EXP 1
154,298,036
154,323,780
RGD:6480464 CTD
G
ATP9A ATPase, class II, type 9A
increases expression
EXP 20
50,213,314
50,384,908
RGD:6480464 CTD
G
ATPAF1 ATP synthase mitochondrial F1 complex assembly factor 1
decreases expression
EXP 1
47,100,711
47,134,099
RGD:6480464 CTD
G
ATPBD4 ATP binding domain 4
increases expression
EXP 15
35,663,170
35,838,404
RGD:6480464 CTD
G
ATPIF1 ATPase inhibitory factor 1
decreases expression
EXP 1
28,562,602
28,564,616
RGD:6480464 CTD
G
ATXN7L4 ataxin 7-like 4
decreases expression
EXP
RGD:6480464 CTD
G
AUH AU RNA binding protein/enoyl-CoA hydratase
decreases expression
EXP 9
93,976,097
94,124,206
RGD:6480464 CTD
G
AURKA aurora kinase A
decreases expression
EXP 20
54,944,445
54,967,351
RGD:6480464 CTD
G
AURKB aurora kinase B
decreases expression
EXP 17
8,108,049
8,113,944
RGD:6480464 CTD
G
AUTS2 autism susceptibility candidate 2
decreases expression
EXP 7
69,063,905
70,257,885
RGD:6480464 CTD
G
AVEN apoptosis, caspase activation inhibitor
increases expression
EXP 15
34,158,428
34,331,303
RGD:6480464 CTD
G
AVL9 AVL9 homolog (S. cerevisiase)
increases expression
EXP 7
32,535,176
32,623,779
RGD:6480464 CTD
G
AVPI1 arginine vasopressin-induced 1
decreases expression
EXP 10
99,437,181
99,447,015
RGD:6480464 CTD
G
AZGP1 alpha-2-glycoprotein 1, zinc-binding
decreases expression
EXP 7
99,564,350
99,573,735
RGD:6480464 CTD
G
AZI2 5-azacytidine induced 2
increases expression
EXP 3
28,363,845
28,390,618
RGD:6480464 CTD
G
AZIN1 antizyme inhibitor 1
increases expression
EXP 8
103,838,536
103,876,397
RGD:6480464 CTD
G
B3GALT6 UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6
increases expression
EXP 1
1,167,629
1,170,421
RGD:6480464 CTD
G
B3GNT1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1
decreases expression
EXP 11
66,112,843
66,115,161
RGD:6480464 CTD
G
B3GNT5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
increases expression
EXP 3
182,971,032
182,991,179
RGD:6480464 CTD
G
B4GALNT1 beta-1,4-N-acetyl-galactosaminyl transferase 1
increases expression
EXP 12
58,019,551
58,026,985
RGD:6480464 CTD
G
B4GALT1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
decreases expression
ISO 9
33,110,639
33,167,356
RGD:6480464 CTD
G
B4GALT3 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3
increases expression
EXP 1
161,141,100
161,147,758
RGD:6480464 CTD
G
B4GALT7 xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7
increases expression
EXP 5
177,027,119
177,037,348
RGD:6480464 CTD
G
B9D1 B9 protein domain 1
increases expression
EXP 17
19,240,867
19,281,495
RGD:6480464 CTD
G
BAAT bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)
decreases expression
EXP 9
104,122,699
104,147,287
RGD:6480464 CTD
G
BACE1 beta-site APP-cleaving enzyme 1
decreases expression
EXP 11
117,156,402
117,186,972
RGD:6480464 CTD
G
BACH1 BTB and CNC homology 1, basic leucine zipper transcription factor 1
increases expression
EXP 21
30,671,220
30,734,217
RGD:6480464 CTD
G
BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2
increases expression
EXP 6
90,636,247
91,006,627
RGD:6480464 CTD
G
BAD BCL2-associated agonist of cell death
multiple interactions
ISO 11
64,037,300
64,052,176
RGD:6480464 CTD
G
BAG2 BCL2-associated athanogene 2
increases expression
EXP 6
57,037,104
57,050,013
RGD:6480464 CTD
G
BAG3 BCL2-associated athanogene 3
increases expression
EXP 10
121,410,882
121,437,331
RGD:6480464 CTD
G
BAG4 BCL2-associated athanogene 4
decreases expression
EXP 8
38,034,106
38,070,819
RGD:6480464 CTD
G
BAIAP2L1 BAI1-associated protein 2-like 1
increases expression
EXP 7
97,920,962
98,030,427
RGD:6480464 CTD
G
BAMBI BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)
decreases expression
EXP 10
28,966,424
28,971,868
RGD:6480464 CTD
G
BARD1 BRCA1 associated RING domain 1
decreases expression
EXP 2
215,593,262
215,674,428
RGD:6480464 CTD
G
BAX BCL2-associated X protein
multiple interactions
ISO 19
49,458,117
49,465,055
RGD:6480464 CTD
G
BAX BCL2-associated X protein
increases expression
EXP 19
49,458,117
49,465,055
RGD:6480464 CTD
G
BBOX1 butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
decreases expression
EXP 11
27,062,509
27,149,354
RGD:6480464 CTD
G
BBS10 Bardet-Biedl syndrome 10
decreases expression
EXP 12
76,738,266
76,742,222
RGD:6480464 CTD
G
BBS4 Bardet-Biedl syndrome 4
increases expression
EXP 15
72,978,520
73,030,817
RGD:6480464 CTD
G
BBS9 Bardet-Biedl syndrome 9
increases expression
EXP 7
33,169,152
33,645,680
RGD:6480464 CTD
G
BCAR3 breast cancer anti-estrogen resistance 3
increases expression
EXP 1
94,027,343
94,312,706
RGD:6480464 CTD
G
BCAS2 breast carcinoma amplified sequence 2
increases expression
EXP 1
115,110,178
115,124,265
RGD:6480464 CTD
G
BCAT1 branched chain amino-acid transaminase 1, cytosolic
increases expression
EXP 12
24,962,958
25,102,393
RGD:6480464 CTD
G
BCAT2 branched chain amino-acid transaminase 2, mitochondrial
decreases expression
EXP 19
49,298,319
49,314,320
RGD:6480464 CTD
G
BCHE butyrylcholinesterase
decreases expression
EXP 3
165,490,692
165,555,253
RGD:6480464 CTD
G
BCKDHB branched chain keto acid dehydrogenase E1, beta polypeptide
decreases expression
EXP 6
80,816,344
81,055,987
RGD:6480464 CTD
G
BCL10 B-cell CLL/lymphoma 10
increases expression
EXP 1
85,731,459
85,742,587
RGD:6480464 CTD
G
BCL2 B-cell CLL/lymphoma 2
multiple interactions
EXP 18
60,790,579
60,986,613
RGD:6480464 CTD
G
BCL2 B-cell CLL/lymphoma 2
increases expression
ISO 18
60,790,579
60,986,613
RGD:6480464 CTD
G
BCL2 B-cell CLL/lymphoma 2
decreases expression
EXP 18
60,790,579
60,986,613
RGD:6480464 CTD
G
BCL2L1 BCL2-like 1
affects expression
EXP 20
30,252,261
30,310,656
RGD:6480464 CTD
G
BCL2L2 BCL2-like 2
increases expression
EXP 14
23,775,971
23,780,968
RGD:6480464 CTD
G
BCL6 B-cell CLL/lymphoma 6
decreases expression
EXP 3
187,439,165
187,463,513
RGD:6480464 CTD
G
BCO2 beta-carotene oxygenase 2
decreases expression
EXP 11
112,046,208
112,089,652
RGD:6480464 CTD
G
BDH1 3-hydroxybutyrate dehydrogenase, type 1
decreases expression
EXP 3
197,236,654
197,300,194
RGD:6480464 CTD
G
BDH2 3-hydroxybutyrate dehydrogenase, type 2
decreases expression
EXP 4
103,998,782
104,021,024
RGD:6480464 CTD
G
BEND7 BEN domain containing 7
increases expression
EXP 10
13,480,484
13,544,976
RGD:6480464 CTD
G
BET1 Bet1 golgi vesicular membrane trafficking protein
increases expression
EXP 7
93,621,000
93,633,690
RGD:6480464 CTD
G
BET1L Bet1 golgi vesicular membrane trafficking protein-like
increases expression
EXP 11
202,924
207,422
RGD:6480464 CTD
G
BEX5 brain expressed, X-linked 5
increases expression
EXP X
101,408,679
101,410,986
RGD:6480464 CTD
G
BHLHB9 basic helix-loop-helix domain containing, class B, 9
decreases expression
EXP X
101,975,642
102,007,369
RGD:6480464 CTD
G
BHLHE40 basic helix-loop-helix family, member e40
increases expression
EXP 3
5,021,097
5,026,866
RGD:6480464 CTD
G
BHMT betaine--homocysteine S-methyltransferase
decreases expression
EXP 5
78,407,604
78,428,113
RGD:6480464 CTD
G
BHMT2 betaine--homocysteine S-methyltransferase 2
decreases expression
EXP 5
78,365,547
78,385,897
RGD:6480464 CTD
G
BICC1 bicaudal C homolog 1 (Drosophila)
decreases expression
EXP 10
60,272,904
60,588,845
RGD:6480464 CTD
G
BID BH3 interacting domain death agonist
increases expression
EXP 22
18,216,906
18,257,431
RGD:6480464 CTD
G
BIN1 bridging integrator 1
increases expression
EXP 2
127,805,599
127,864,903
RGD:6480464 CTD
G
BIRC2 baculoviral IAP repeat containing 2
increases expression
EXP 11
102,217,913
102,249,401
RGD:6480464 CTD
G
BIRC3 baculoviral IAP repeat containing 3
increases expression
EXP 11
102,188,181
102,210,134
RGD:6480464 CTD
G
BIRC5 baculoviral IAP repeat containing 5
decreases expression
EXP 17
76,210,277
76,221,716
RGD:6480464 CTD
G
BIRC5 baculoviral IAP repeat containing 5
decreases expression
ISO 17
76,210,277
76,221,716
RGD:6480464 CTD
G
BIVM basic, immunoglobulin-like variable motif containing
decreases expression
EXP 13
103,451,399
103,493,888
RGD:6480464 CTD
G
BLM Bloom syndrome, RecQ helicase-like
decreases expression
EXP 15
91,260,579
91,358,686
RGD:6480464 CTD
G
BLM Bloom syndrome, RecQ helicase-like
decreases expression
ISO 15
91,260,579
91,358,686
RGD:6480464 CTD
G
BLNK B-cell linker
decreases expression
EXP 10
97,951,455
98,031,333
RGD:6480464 CTD
G
BLOC1S1 biogenesis of lysosomal organelles complex-1, subunit 1
decreases expression
EXP 12
56,109,818
56,113,491
RGD:6480464 CTD
G
BLOC1S2 biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
EXP 10
102,033,035
102,046,469
RGD:6480464 CTD
G
BLVRB biliverdin reductase B (flavin reductase (NADPH))
increases expression
EXP 19
40,953,691
40,971,725
RGD:6480464 CTD
G
BLZF1 basic leucine zipper nuclear factor 1
increases expression
EXP 1
169,337,194
169,365,782
RGD:6480464 CTD
G
BNIP1 BCL2/adenovirus E1B 19kDa interacting protein 1
increases expression
EXP 5
172,571,445
172,591,390
RGD:6480464 CTD
G
BNIP2 BCL2/adenovirus E1B 19kDa interacting protein 2
increases expression
EXP 15
59,955,061
59,981,642
RGD:6480464 CTD
G
BNIP3L BCL2/adenovirus E1B 19kDa interacting protein 3-like
increases expression
EXP 8
26,240,523
26,270,644
RGD:6480464 CTD
G
BOD1 biorientation of chromosomes in cell division 1
increases expression
EXP 5
173,034,148
173,043,666
RGD:6480464 CTD
G
BOK BCL2-related ovarian killer
decreases expression
EXP 2
242,498,146
242,513,553
RGD:6480464 CTD
G
BOLA3 bolA homolog 3 (E. coli)
decreases expression
EXP 2
74,362,528
74,375,039
RGD:6480464 CTD
G
BORA bora, aurora kinase A activator
affects expression
EXP 13
73,302,042
73,330,328
RGD:6480464 CTD
G
BPHL biphenyl hydrolase-like (serine hydrolase)
decreases expression
EXP 6
3,118,926
3,153,432
RGD:6480464 CTD
G
BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1
decreases expression
EXP 1
220,230,824
220,263,191
RGD:6480464 CTD
G
BRAP BRCA1 associated protein
increases expression
EXP 12
112,079,950
112,123,790
RGD:6480464 CTD
G
BRCA1 breast cancer 1, early onset
decreases expression
ISO 17
41,196,312
41,277,500
RGD:6480464 CTD
G
BRCA2 breast cancer 2, early onset
decreases expression
EXP 13
32,889,617
32,973,809
RGD:6480464 CTD
G
BRD1 bromodomain containing 1
increases expression
EXP 22
50,166,937
50,218,452
RGD:6480464 CTD
G
BRF2 BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like
increases expression
EXP 8
37,701,398
37,707,431
RGD:6480464 CTD
G
BRIP1 BRCA1 interacting protein C-terminal helicase 1
decreases expression
EXP 17
59,756,547
59,940,920
RGD:6480464 CTD
G
BRK1 BRICK1, SCAR/WAVE actin-nucleating complex subunit
decreases expression
EXP 3
10,157,333
10,168,874
RGD:6480464 CTD
G
BSCL2 Berardinelli-Seip congenital lipodystrophy 2 (seipin)
decreases expression
EXP 11
62,457,734
62,477,091
RGD:6480464 CTD
G
BTAF1 BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)
increases expression
EXP 10
93,683,736
93,790,082
RGD:6480464 CTD
G
BTBD10 BTB (POZ) domain containing 10
increases expression
EXP 11
13,409,555
13,484,838
RGD:6480464 CTD
G
BTC betacellulin
increases expression
EXP 4
75,671,448
75,719,882
RGD:6480464 CTD
G
BTD biotinidase
decreases expression
EXP 3
15,643,255
15,687,325
RGD:6480464 CTD
G
BTF3L4 basic transcription factor 3-like 4
increases expression
EXP 1
52,521,857
52,556,388
RGD:6480464 CTD
G
BTG3 BTG family, member 3
increases expression
EXP 21
18,965,968
18,985,268
RGD:6480464 CTD
G
BTN2A1 butyrophilin, subfamily 2, member A1
increases expression
EXP 6
26,458,153
26,476,849
RGD:6480464 CTD
G
BTN3A1 butyrophilin, subfamily 3, member A1
increases expression
EXP 6
26,402,465
26,415,444
RGD:6480464 CTD
G
BTN3A2 butyrophilin, subfamily 3, member A2
increases expression
EXP 6
26,365,398
26,378,548
RGD:6480464 CTD
G
BTN3A3 butyrophilin, subfamily 3, member A3
increases expression
EXP 6
26,440,700
26,453,643
RGD:6480464 CTD
G
BTNL10 butyrophilin-like 10
decreases expression
ISO 1
228,696,347
228,699,989
RGD:6480464 CTD
G
BTNL8 butyrophilin-like 8
decreases expression
EXP 5
180,326,077
180,377,906
RGD:6480464 CTD
G
BUB1 BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
EXP 2
111,395,409
111,435,684
RGD:6480464 CTD
G
BUB1 BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO 2
111,395,409
111,435,684
RGD:6480464 CTD
G
BUB1B BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
EXP 15
40,453,210
40,513,337
RGD:6480464 CTD
G
BUD31 BUD31 homolog (S. cerevisiae)
increases expression
EXP 7
99,006,601
99,017,239
RGD:6480464 CTD
G
BYSL bystin-like
increases expression
EXP 6
41,888,965
41,900,784
RGD:6480464 CTD
G
C10orf10 chromosome 10 open reading frame 10
affects expression
EXP 10
45,471,709
45,474,330
RGD:6480464 CTD
G
C10orf114 chromosome 10 open reading frame 114
decreases expression
EXP 10
21,783,421
21,786,213
RGD:6480464 CTD
G
C10orf118 chromosome 10 open reading frame 118
increases expression
EXP 10
115,881,974
115,934,364
RGD:6480464 CTD
G
C11orf52 chromosome 11 open reading frame 52
decreases expression
EXP 11
111,789,601
111,797,595
RGD:6480464 CTD
G
C11orf54 chromosome 11 open reading frame 54
decreases expression
EXP 11
93,474,793
93,496,247
RGD:6480464 CTD
G
C11orf73 chromosome 11 open reading frame 73
increases expression
EXP 11
86,013,253
86,056,985
RGD:6480464 CTD
G
C11orf92 chromosome 11 open reading frame 92
increases expression
EXP 11
111,164,114
111,170,539
RGD:6480464 CTD
G
C11orf95 chromosome 11 open reading frame 95
decreases expression
EXP 11
63,527,364
63,536,113
RGD:6480464 CTD
G
C12orf23 chromosome 12 open reading frame 23
increases expression
EXP 12
107,349,544
107,367,813
RGD:6480464 CTD
G
C12orf39 chromosome 12 open reading frame 39
increases expression
EXP 12
21,679,256
21,684,210
RGD:6480464 CTD
G
C12orf4 chromosome 12 open reading frame 4
increases expression
EXP 12
4,596,901
4,647,637
RGD:6480464 CTD
G
C12orf44 chromosome 12 open reading frame 44
increases expression
EXP 12
52,463,758
52,471,279
RGD:6480464 CTD
G
C12orf49 chromosome 12 open reading frame 49
increases expression
EXP 12
117,153,596
117,175,843
RGD:6480464 CTD
G
C12orf5 chromosome 12 open reading frame 5
increases expression
EXP 12
4,430,359
4,469,194
RGD:6480464 CTD
G
C12orf57 chromosome 12 open reading frame 57
increases expression
EXP 12
7,053,203
7,055,165
RGD:6480464 CTD
G
C12orf61 chromosome 12 open reading frame 61
increases expression
EXP 12
62,995,531
62,997,214
RGD:6480464 CTD
G
C12orf75 chromosome 12 open reading frame 75
decreases expression
EXP 12
105,724,414
105,765,296
RGD:6480464 CTD
G
C14orf1 chromosome 14 open reading frame 1
decreases expression
EXP 14
76,117,233
76,127,538
RGD:6480464 CTD
G
C14orf105 chromosome 14 open reading frame 105
decreases expression
EXP 14
57,936,595
57,960,576
RGD:6480464 CTD
G
C14orf142 chromosome 14 open reading frame 142
decreases expression
EXP 14
93,669,237
93,673,459
RGD:6480464 CTD
G
C14orf166 chromosome 14 open reading frame 166
increases expression
EXP 14
52,456,228
52,471,420
RGD:6480464 CTD
G
C14orf2 chromosome 14 open reading frame 2
decreases expression
EXP 14
104,378,625
104,387,903
RGD:6480464 CTD
G
C14orf28 chromosome 14 open reading frame 28
increases expression
EXP 14
45,366,507
45,376,460
RGD:6480464 CTD
G
C15orf52 chromosome 15 open reading frame 52
increases expression
EXP 15
40,623,653
40,633,168
RGD:6480464 CTD
G
C15orf57 chromosome 15 open reading frame 57
increases expression
EXP 15
40,845,298
40,857,252
RGD:6480464 CTD
G
C16orf62 chromosome 16 open reading frame 62
decreases expression
EXP 16
19,566,737
19,712,485
RGD:6480464 CTD
G
C16orf70 chromosome 16 open reading frame 70
decreases expression
EXP 16
67,143,915
67,182,442
RGD:6480464 CTD
G
C16orf72 chromosome 16 open reading frame 72
increases expression
EXP 16
9,185,537
9,213,555
RGD:6480464 CTD
G
C16orf80 chromosome 16 open reading frame 80
decreases expression
EXP 16
58,147,496
58,163,296
RGD:6480464 CTD
G
C17orf100 chromosome 17 open reading frame 100
increases expression
EXP 17
6,555,059
6,556,617
RGD:6480464 CTD
G
C17orf76-AS1 C17orf76 antisense RNA 1
increases expression
EXP 17
16,342,301
16,373,962
RGD:6480464 CTD
G
C18orf8 chromosome 18 open reading frame 8
increases expression
EXP 18
21,083,462
21,111,746
RGD:6480464 CTD
G
C19orf10 chromosome 19 open reading frame 10
increases expression
EXP 19
4,657,557
4,670,415
RGD:6480464 CTD
G
C19orf12 chromosome 19 open reading frame 12
decreases expression
EXP 19
30,189,793
30,206,696
RGD:6480464 CTD
G
C19orf48 chromosome 19 open reading frame 48
increases expression
EXP 19
51,300,961
51,307,974
RGD:6480464 CTD
G
C1GALT1C1 C1GALT1-specific chaperone 1
decreases expression
EXP X
119,759,529
119,764,005
RGD:6480464 CTD
G
C1orf109 chromosome 1 open reading frame 109
increases expression
EXP 1
38,147,242
38,156,192
RGD:6480464 CTD
G
C1orf112 chromosome 1 open reading frame 112
decreases expression
EXP 1
169,764,550
169,822,229
RGD:6480464 CTD
G
C1orf115 chromosome 1 open reading frame 115
decreases expression
EXP 1
220,863,628
220,872,499
RGD:6480464 CTD
G
C1orf122 chromosome 1 open reading frame 122
increases expression
EXP 1
38,273,473
38,275,126
RGD:6480464 CTD
G
C1orf131 chromosome 1 open reading frame 131
decreases expression
EXP 1
231,359,509
231,376,924
RGD:6480464 CTD
G
C1orf168 chromosome 1 open reading frame 168
decreases expression
EXP 1
57,184,477
57,285,369
RGD:6480464 CTD
G
C1orf21 chromosome 1 open reading frame 21
decreases expression
EXP 1
184,356,150
184,598,155
RGD:6480464 CTD
G
C1orf216 chromosome 1 open reading frame 216
increases expression
EXP 1
36,179,477
36,184,790
RGD:6480464 CTD
G
C1orf226 chromosome 1 open reading frame 226
decreases expression
EXP 1
162,348,696
162,356,608
RGD:6480464 CTD
G
C1orf52 chromosome 1 open reading frame 52
increases expression
EXP 1
85,715,636
85,725,355
RGD:6480464 CTD
G
C1orf53 chromosome 1 open reading frame 53
decreases expression
EXP 1
197,871,682
197,876,497
RGD:6480464 CTD
G
C1orf67 chromosome 1 open reading frame 67
increases expression
EXP
RGD:6480464 CTD
G
C1orf74 chromosome 1 open reading frame 74
decreases expression
EXP 1
209,955,662
209,957,890
RGD:6480464 CTD
G
C1orf85 chromosome 1 open reading frame 85
decreases expression
EXP 1
156,262,478
156,265,480
RGD:6480464 CTD
G
C1QL1 complement component 1, q subcomponent-like 1
decreases expression
EXP 17
43,037,061
43,045,644
RGD:6480464 CTD
G
C1QTNF1 C1q and tumor necrosis factor related protein 1
decreases expression
EXP 17
77,019,016
77,045,870
RGD:6480464 CTD
G
C1R complement component 1, r subcomponent
decreases expression
EXP 12
7,241,205
7,245,043
RGD:6480464 CTD
G
C1RL complement component 1, r subcomponent-like
decreases expression
EXP 12
7,247,146
7,261,869
RGD:6480464 CTD
G
C1S complement component 1, s subcomponent
decreases expression
EXP 12
7,167,980
7,178,336
RGD:6480464 CTD
G
C2 complement component 2
decreases expression
EXP 6
31,865,562
31,913,449
RGD:6480464 CTD
G
C20orf111 chromosome 20 open reading frame 111
increases expression
EXP 20
42,824,579
42,839,546
RGD:6480464 CTD
G
C20orf194 chromosome 20 open reading frame 194
increases expression
EXP 20
3,229,948
3,388,309
RGD:6480464 CTD
G
C21orf119 chromosome 21 open reading frame 119
increases expression
EXP 21
33,765,442
33,766,269
RGD:6480464 CTD
G
C21orf33 chromosome 21 open reading frame 33
decreases expression
EXP 21
45,553,494
45,565,605
RGD:6480464 CTD
G
C21orf91 chromosome 21 open reading frame 91
increases expression
EXP 21
19,161,284
19,191,703
RGD:6480464 CTD
G
C2CD4A C2 calcium-dependent domain containing 4A
increases expression
EXP 15
62,359,176
62,363,116
RGD:6480464 CTD
G
C2orf88 chromosome 2 open reading frame 88
decreases expression
EXP 2
191,002,486
191,068,210
RGD:6480464 CTD
G
C3 complement component 3
decreases expression
EXP 19
6,677,846
6,720,662
RGD:6480464 CTD
G
C3orf14 chromosome 3 open reading frame 14
decreases expression
EXP 3
62,305,396
62,319,321
RGD:6480464 CTD
G
C3orf52 chromosome 3 open reading frame 52
increases expression
EXP 3
111,805,182
111,837,073
RGD:6480464 CTD
G
C4BPA complement component 4 binding protein, alpha
decreases expression
EXP 1
207,277,607
207,318,317
RGD:6480464 CTD
G
C4BPB complement component 4 binding protein, beta
decreases expression
EXP 1
207,262,212
207,273,338
RGD:6480464 CTD
G
C4orf19 chromosome 4 open reading frame 19
decreases expression
EXP 4
37,455,552
37,595,132
RGD:6480464 CTD
G
C4orf32 chromosome 4 open reading frame 32
increases expression
EXP 4
113,066,553
113,110,237
RGD:6480464 CTD
G
C4orf33 chromosome 4 open reading frame 33
decreases expression
EXP 4
130,014,829
130,033,843
RGD:6480464 CTD
G
C5 complement component 5
decreases expression
EXP 9
123,714,613
123,812,554
RGD:6480464 CTD
G
C5AR1 complement component 5a receptor 1
increases expression
EXP 19
47,813,104
47,825,327
RGD:6480464 CTD
G
C5orf28 chromosome 5 open reading frame 28
increases expression
EXP 5
43,444,354
43,483,992
RGD:6480464 CTD
G
C6 complement component 6
decreases expression
EXP 5
41,142,336
41,261,540
RGD:6480464 CTD
G
C6orf1 chromosome 6 open reading frame 1
increases expression
EXP 6
34,214,157
34,216,904
RGD:6480464 CTD
G
C6orf136 chromosome 6 open reading frame 136
decreases expression
EXP 6
30,614,816
30,620,987
RGD:6480464 CTD
G
C6orf170 chromosome 6 open reading frame 170
increases expression
EXP 6
121,400,627
121,655,644
RGD:6480464 CTD
G
C6orf203 chromosome 6 open reading frame 203
decreases expression
EXP 6
107,349,407
107,372,546
RGD:6480464 CTD
G
C6orf211 chromosome 6 open reading frame 211
decreases expression
EXP 6
151,773,422
151,791,232
RGD:6480464 CTD
G
C6orf48 chromosome 6 open reading frame 48
increases expression
EXP 6
31,802,693
31,807,541
RGD:6480464 CTD
G
C6orf57 chromosome 6 open reading frame 57
decreases expression
EXP 6
71,276,625
71,298,606
RGD:6480464 CTD
G
C6orf62 chromosome 6 open reading frame 62
increases expression
EXP 6
24,705,089
24,719,403
RGD:6480464 CTD
G
C7orf10 chromosome 7 open reading frame 10
decreases expression
EXP 7
40,174,575
40,900,366
RGD:6480464 CTD
G
C7orf29 chromosome 7 open reading frame 29
decreases expression
EXP 7
150,026,938
150,029,810
RGD:6480464 CTD
G
C7orf41 chromosome 7 open reading frame 41
decreases expression
EXP 7
30,174,552
30,202,381
RGD:6480464 CTD
G
C7orf55 chromosome 7 open reading frame 55
decreases expression
EXP 7
139,025,196
139,031,065
RGD:6480464 CTD
G
C8A complement component 8, alpha polypeptide
decreases expression
EXP 1
57,320,443
57,383,894
RGD:6480464 CTD
G
C8B complement component 8, beta polypeptide
decreases expression
EXP 1
57,394,883
57,431,688
RGD:6480464 CTD
G
C8G complement component 8, gamma polypeptide
decreases expression
EXP 9
139,839,698
139,841,426
RGD:6480464 CTD
G
C8orf22 chromosome 8 open reading frame 22
increases expression
EXP 8
49,966,895
49,988,642
RGD:6480464 CTD
G
C8orf4 chromosome 8 open reading frame 4
increases expression
EXP 8
40,010,987
40,012,827
RGD:6480464 CTD
G
C8orf47 chromosome 8 open reading frame 47
decreases expression
EXP 8
99,076,750
99,105,838
RGD:6480464 CTD
G
C8orf58 chromosome 8 open reading frame 58
decreases expression
EXP 8
22,457,114
22,461,663
RGD:6480464 CTD
G
C8orf76 chromosome 8 open reading frame 76
increases expression
EXP 8
124,232,196
124,253,638
RGD:6480464 CTD
G
C9orf156 chromosome 9 open reading frame 156
increases expression
EXP 9
100,666,772
100,684,852
RGD:6480464 CTD
G
C9orf3 chromosome 9 open reading frame 3
decreases expression
EXP 9
97,488,951
97,849,500
RGD:6480464 CTD
G
C9orf72 chromosome 9 open reading frame 72
increases expression
EXP 9
27,546,543
27,573,864
RGD:6480464 CTD
G
C9orf85 chromosome 9 open reading frame 85
increases expression
EXP 9
74,526,423
74,588,373
RGD:6480464 CTD
G
C9orf91 chromosome 9 open reading frame 91
increases expression
EXP 9
117,373,706
117,408,703
RGD:6480464 CTD
G
CA12 carbonic anhydrase XII
increases expression
EXP 15
63,615,730
63,674,075
RGD:6480464 CTD
G
CA13 carbonic anhydrase XIII
increases expression
EXP 8
86,157,716
86,196,302
RGD:6480464 CTD
G
CA2 carbonic anhydrase II
decreases expression
EXP 8
86,376,131
86,393,721
RGD:6480464 CTD
G
CA8 carbonic anhydrase VIII
increases expression
EXP 8
61,101,423
61,193,954
RGD:6480464 CTD
G
CA9 carbonic anhydrase IX
decreases expression
EXP 9
35,673,915
35,681,156
RGD:6480464 CTD
G
CACHD1 cache domain containing 1
decreases expression
EXP 1
64,936,476
65,158,741
RGD:6480464 CTD
G
CACNB2 calcium channel, voltage-dependent, beta 2 subunit
decreases expression
EXP 10
18,429,606
18,830,688
RGD:6480464 CTD
G
CACYBP calcyclin binding protein
increases expression
EXP 1
174,968,571
174,981,163
RGD:6480464 CTD
G
CADM1 cell adhesion molecule 1
decreases expression
EXP 11
115,044,345
115,375,241
RGD:6480464 CTD
G
CADM2 cell adhesion molecule 2
increases expression
EXP 3
85,008,133
86,123,579
RGD:6480464 CTD
G
CADPS2 Ca++-dependent secretion activator 2
increases expression
EXP 7
121,958,478
122,526,813
RGD:6480464 CTD
G
CALB2 calbindin 2
increases expression
EXP 16
71,392,616
71,424,341
RGD:6480464 CTD
G
CALCRL calcitonin receptor-like
decreases expression
EXP 2
188,207,846
188,313,021
RGD:6480464 CTD
G
CALM3 calmodulin 3 (phosphorylase kinase, delta)
decreases expression
EXP 19
47,104,512
47,114,039
RGD:6480464 CTD
G
CALML4 calmodulin-like 4
decreases expression
EXP 15
68,483,043
68,498,448
RGD:6480464 CTD
G
CALR calreticulin
increases expression
ISO 19
13,049,414
13,055,304
RGD:6480464 CTD
G
CALU calumenin
increases expression
EXP 7
128,379,346
128,413,477
RGD:6480464 CTD
G
CAMK2A calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
ISO 5
149,599,054
149,669,403
RGD:6480464 CTD
G
CAMK2N1 calcium/calmodulin-dependent protein kinase II inhibitor 1
decreases expression
EXP 1
20,808,884
20,812,728
RGD:6480464 CTD
G
CAMK4 calcium/calmodulin-dependent protein kinase IV
multiple interactions
ISO 5
110,559,947
110,820,749
RGD:6480464 CTD
G
CAMLG calcium modulating ligand
increases expression
EXP 5
134,074,170
134,087,850
RGD:6480464 CTD
G
CAMSAP1 calmodulin regulated spectrin-associated protein 1
increases expression
EXP 9
138,700,333
138,799,005
RGD:6480464 CTD
G
CAMSAP2 calmodulin regulated spectrin-associated protein family, member 2
increases expression
EXP 1
200,708,686
200,829,832
RGD:6480464 CTD
G
CAMSAP3 calmodulin regulated spectrin-associated protein family, member 3
decreases expression
EXP 19
7,660,788
7,683,196
RGD:6480464 CTD
G
CAMTA2 calmodulin binding transcription activator 2
increases expression
EXP 17
4,871,287
4,890,960
RGD:6480464 CTD
G
CANX calnexin
increases expression
EXP 5
179,125,930
179,158,642
RGD:6480464 CTD
G
CANX calnexin
increases expression
ISO 5
179,125,930
179,158,642
RGD:6480464 CTD
G
CAPN1 calpain 1, (mu/I) large subunit
decreases expression
EXP 11
64,948,686
64,979,477
RGD:6480464 CTD
G
CAPN2 calpain 2, (m/II) large subunit
increases expression
EXP 1
223,889,295
223,963,720
RGD:6480464 CTD
G
CAPN7 calpain 7
increases expression
EXP 3
15,247,733
15,294,423
RGD:6480464 CTD
G
CARD10 caspase recruitment domain family, member 10
decreases expression
EXP 22
37,886,400
37,915,210
RGD:6480464 CTD
G
CARD16 caspase recruitment domain family, member 16
decreases expression
EXP 11
104,912,053
104,916,051
RGD:6480464 CTD
G
CARD18 caspase recruitment domain family, member 18
increases expression
EXP 11
105,008,448
105,010,461
RGD:6480464 CTD
G
CARD6 caspase recruitment domain family, member 6
decreases expression
EXP 5
40,841,410
40,855,456
RGD:6480464 CTD
G
CARD8 caspase recruitment domain family, member 8
increases expression
EXP 19
48,711,343
48,759,203
RGD:6480464 CTD
G
CARS cysteinyl-tRNA synthetase
increases expression
EXP 11
3,022,152
3,078,681
RGD:6480464 CTD
G
CASK calcium/calmodulin-dependent serine protein kinase (MAGUK family)
increases expression
EXP X
41,374,187
41,782,287
RGD:6480464 CTD
G
CASP1 caspase 1, apoptosis-related cysteine peptidase
decreases expression
EXP 11
104,896,235
104,905,884
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
increases activity
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
increases activity
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP3 caspase 3, apoptosis-related cysteine peptidase
multiple interactions
ISO 4
185,548,850
185,570,629
RGD:6480464 CTD
G
CASP4 caspase 4, apoptosis-related cysteine peptidase
increases expression
EXP 11
104,813,594
104,839,325
RGD:6480464 CTD
G
CASP6 caspase 6, apoptosis-related cysteine peptidase
decreases expression
EXP 4
110,609,785
110,624,629
RGD:6480464 CTD
G
CASP7 caspase 7, apoptosis-related cysteine peptidase
increases expression
EXP 10
115,438,921
115,490,668
RGD:6480464 CTD
G
CASP8 caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP 2
202,098,166
202,152,434
RGD:6480464 CTD
G
CASP8 caspase 8, apoptosis-related cysteine peptidase
multiple interactions
ISO 2
202,098,166
202,152,434
RGD:6480464 CTD
G
CASP9 caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP 1
15,818,769
15,851,285
RGD:6480464 CTD
G
CAT catalase
decreases expression
EXP 11
34,460,472
34,493,607
RGD:6480464 CTD
G
CAT catalase
multiple interactions
ISO 11
34,460,472
34,493,607
RGD:6480464 CTD
G
CAT catalase
increases expression
ISO 11
34,460,472
34,493,607
RGD:6480464 CTD
G
CAT catalase
increases activity
ISO 11
34,460,472
34,493,607
RGD:6480464 CTD
G
CAV1 caveolin 1, caveolae protein, 22kDa
decreases expression
EXP 7
116,164,839
116,201,239
RGD:6480464 CTD
G
CAV2 caveolin 2
decreases expression
EXP 7
116,139,655
116,148,595
RGD:6480464 CTD
G
CBFA2T2 core-binding factor, runt domain, alpha subunit 2; translocated to, 2
increases expression
EXP 20
32,077,928
32,237,837
RGD:6480464 CTD
G
CBFB core-binding factor, beta subunit
increases expression
EXP 16
67,063,050
67,134,961
RGD:6480464 CTD
G
CBLB Cbl proto-oncogene, E3 ubiquitin protein ligase B
increases expression
EXP 3
105,377,109
105,587,887
RGD:6480464 CTD
G
CBLL1 Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1
increases expression
EXP 7
107,384,279
107,402,083
RGD:6480464 CTD
G
CBR1 carbonyl reductase 1
decreases expression
EXP 21
37,442,285
37,445,462
RGD:6480464 CTD
G
CBR3 carbonyl reductase 3
increases expression
EXP 21
37,507,263
37,518,860
RGD:6480464 CTD
G
CBR4 carbonyl reductase 4
decreases expression
EXP 4
169,908,741
169,931,468
RGD:6480464 CTD
G
CBS cystathionine-beta-synthase
increases expression
EXP 21
44,473,301
44,496,472
RGD:6480464 CTD
G
CBX4 chromobox homolog 4
increases expression
EXP 17
77,806,955
77,813,213
RGD:6480464 CTD
G
CBX5 chromobox homolog 5
decreases expression
EXP 12
54,624,730
54,673,915
RGD:6480464 CTD
G
CBX6 chromobox homolog 6
decreases expression
EXP 22
39,260,243
39,268,258
RGD:6480464 CTD
G
CBX7 chromobox homolog 7
decreases expression
EXP 22
39,526,777
39,548,538
RGD:6480464 CTD
G
CCBL1 cysteine conjugate-beta lyase, cytoplasmic
decreases expression
EXP 9
131,595,392
131,644,354
RGD:6480464 CTD
G
CCDC104 coiled-coil domain containing 104
increases expression
EXP 2
55,746,740
55,772,216
RGD:6480464 CTD
G
CCDC109B coiled-coil domain containing 109B
increases expression
EXP 4
110,481,355
110,608,872
RGD:6480464 CTD
G
CCDC110 coiled-coil domain containing 110
increases expression
EXP 4
186,366,336
186,392,913
RGD:6480464 CTD
G
CCDC111 coiled-coil domain containing 111
increases expression
EXP 4
185,570,767
185,616,112
RGD:6480464 CTD
G
CCDC113 coiled-coil domain containing 113
increases expression
EXP 16
58,283,840
58,317,740
RGD:6480464 CTD
G
CCDC125 coiled-coil domain containing 125
decreases expression
EXP 5
68,576,519
68,616,410
RGD:6480464 CTD
G
CCDC130 coiled-coil domain containing 130
increases expression
EXP 19
13,858,753
13,874,106
RGD:6480464 CTD
G
CCDC142 coiled-coil domain containing 142
decreases expression
EXP 2
74,699,959
74,710,357
RGD:6480464 CTD
G
CCDC15 coiled-coil domain containing 15
decreases expression
EXP 11
124,824,017
124,911,385
RGD:6480464 CTD
G
CCDC150 coiled-coil domain containing 150
decreases expression
EXP 2
197,504,356
197,597,530
RGD:6480464 CTD
G
CCDC167 coiled-coil domain containing 167
increases expression
EXP 6
37,450,696
37,467,700
RGD:6480464 CTD
G
CCDC170 coiled-coil domain containing 170
decreases expression
EXP 6
151,815,175
151,942,328
RGD:6480464 CTD
G
CCDC176 coiled-coil domain containing 176
increases expression
EXP 14
74,486,059
74,532,795
RGD:6480464 CTD
G
CCDC178 coiled-coil domain containing 178
increases expression
EXP 18
30,517,366
31,020,685
RGD:6480464 CTD
G
CCDC18 coiled-coil domain containing 18
increases expression
EXP 1
93,646,281
93,744,287
RGD:6480464 CTD
G
CCDC25 coiled-coil domain containing 25
decreases expression
EXP 8
27,590,833
27,630,170
RGD:6480464 CTD
G
CCDC34 coiled-coil domain containing 34
decreases expression
EXP 11
27,360,061
27,384,795
RGD:6480464 CTD
G
CCDC50 coiled-coil domain containing 50
increases expression
EXP 3
191,046,874
191,116,459
RGD:6480464 CTD
G
CCDC59 coiled-coil domain containing 59
increases expression
EXP 12
82,746,083
82,752,584
RGD:6480464 CTD
G
CCDC6 coiled-coil domain containing 6
increases expression
EXP 10
61,548,505
61,666,414
RGD:6480464 CTD
G
CCDC66 coiled-coil domain containing 66
increases expression
EXP 3
56,591,184
56,655,864
RGD:6480464 CTD
G
CCDC68 coiled-coil domain containing 68
decreases expression
EXP 18
52,568,740
52,626,739
RGD:6480464 CTD
G
CCDC69 coiled-coil domain containing 69
decreases expression
EXP 5
150,560,613
150,603,654
RGD:6480464 CTD
G
CCDC77 coiled-coil domain containing 77
decreases expression
EXP 12
498,516
551,808
RGD:6480464 CTD
G
CCDC82 coiled-coil domain containing 82
increases expression
EXP 11
96,085,929
96,123,083
RGD:6480464 CTD
G
CCDC84 coiled-coil domain containing 84
increases expression
EXP 11
118,868,852
118,886,455
RGD:6480464 CTD
G
CCDC86 coiled-coil domain containing 86
increases expression
EXP 11
60,609,429
60,618,561
RGD:6480464 CTD
G
CCDC90B coiled-coil domain containing 90B
increases expression
EXP 11
82,972,506
82,997,377
RGD:6480464 CTD
G
CCDC91 coiled-coil domain containing 91
increases expression
EXP 12
28,410,133
28,703,099
RGD:6480464 CTD
G
CCDC93 coiled-coil domain containing 93
increases expression
EXP 2
118,673,054
118,771,739
RGD:6480464 CTD
G
CCL15 chemokine (C-C motif) ligand 15
decreases expression
EXP 17
34,324,618
34,329,084
RGD:6480464 CTD
G
CCL20 chemokine (C-C motif) ligand 20
increases expression
EXP 2
228,678,558
228,682,280
RGD:6480464 CTD
G
CCNA2 cyclin A2
decreases expression
EXP 4
122,737,599
122,745,088
RGD:6480464 CTD
G
CCNA2 cyclin A2
decreases expression
ISO 4
122,737,599
122,745,088
RGD:6480464 CTD
G
CCNB1 cyclin B1
decreases expression
EXP 5
68,462,837
68,474,072
RGD:6480464 CTD
G
CCNB1 cyclin B1
decreases expression
ISO 5
68,462,837
68,474,072
RGD:6480464 CTD
G
CCNB2 cyclin B2
decreases expression
EXP 15
59,397,284
59,417,244
RGD:6480464 CTD
G
CCNB2 cyclin B2
decreases expression
ISO 15
59,397,284
59,417,244
RGD:6480464 CTD
G
CCND1 cyclin D1
decreases expression
ISO 11
69,455,873
69,469,242
RGD:6480464 CTD
G
CCND2 cyclin D2
increases expression
EXP 12
4,382,902
4,414,522
RGD:6480464 CTD
G
CCNE2 cyclin E2
increases expression
EXP 8
95,892,452
95,907,482
RGD:6480464 CTD
G
CCNE2 cyclin E2
decreases expression
ISO 8
95,892,452
95,907,482
RGD:6480464 CTD
G
CCNG2 cyclin G2
increases expression
EXP 4
78,078,357
78,091,213
RGD:6480464 CTD
G
CCNI cyclin I
increases expression
EXP 4
77,969,165
77,997,125
RGD:6480464 CTD
G
CCNJL cyclin J-like
increases expression
EXP 5
159,678,671
159,739,573
RGD:6480464 CTD
G
CCNL1 cyclin L1
increases expression
EXP 3
156,865,585
156,878,482
RGD:6480464 CTD
G
CCNO cyclin O
increases expression
EXP 5
54,526,980
54,529,508
RGD:6480464 CTD
G
CCNT2 cyclin T2
increases expression
EXP 2
135,676,392
135,716,915
RGD:6480464 CTD
G
CCNYL1 cyclin Y-like 1
increases expression
EXP 2
208,576,264
208,620,898
RGD:6480464 CTD
G
CCP110 centriolar coiled coil protein 110kDa
increases expression
EXP 16
19,535,179
19,564,730
RGD:6480464 CTD
G
CCPG1 cell cycle progression 1
increases expression
EXP 15
55,647,421
55,700,708
RGD:6480464 CTD
G
CCR2 chemokine (C-C motif) receptor 2
increases expression
EXP 3
46,395,235
46,402,413
RGD:6480464 CTD
G
CCR7 chemokine (C-C motif) receptor 7
increases expression
EXP 17
38,710,021
38,721,736
RGD:6480464 CTD
G
CCRL2 chemokine (C-C motif) receptor-like 2
increases expression
EXP 3
46,448,721
46,451,014
RGD:6480464 CTD
G
CCT4 chaperonin containing TCP1, subunit 4 (delta)
increases expression
EXP 2
62,095,262
62,115,806
RGD:6480464 CTD
G
CCT5 chaperonin containing TCP1, subunit 5 (epsilon)
increases expression
EXP 5
10,250,282
10,266,501
RGD:6480464 CTD
G
CCT6A chaperonin containing TCP1, subunit 6A (zeta 1)
increases expression
EXP 7
56,119,378
56,131,682
RGD:6480464 CTD
G
CD14 CD14 molecule
decreases expression
EXP 5
140,011,313
140,013,286
RGD:6480464 CTD
G
CD1D CD1d molecule
decreases expression
EXP 1
158,149,737
158,156,217
RGD:6480464 CTD
G
CD302 CD302 molecule
decreases expression
EXP 2
160,625,139
160,654,766
RGD:6480464 CTD
G
CD44 CD44 molecule (Indian blood group)
increases expression
EXP 11
35,160,417
35,253,949
RGD:6480464 CTD
G
CD55 CD55 molecule, decay accelerating factor for complement (Cromer blood group)
increases expression
EXP 1
207,494,817
207,534,311
RGD:6480464 CTD
G
CD58 CD58 molecule
increases expression
EXP 1
117,057,156
117,113,715
RGD:6480464 CTD
G
CD59 CD59 molecule, complement regulatory protein
decreases expression
EXP 11
33,724,556
33,758,025
RGD:6480464 CTD
G
CD63 CD63 molecule
increases expression
EXP 12
56,119,227
56,123,457
RGD:6480464 CTD
G
CD68 CD68 molecule
decreases expression
EXP 17
7,482,805
7,485,429
RGD:6480464 CTD
G
CD81 CD81 molecule
decreases expression
EXP 11
2,398,547
2,418,649
RGD:6480464 CTD
G
CD9 CD9 molecule
increases expression
EXP 12
6,309,482
6,347,437
RGD:6480464 CTD
G
CDA cytidine deaminase
affects expression
EXP 1
20,915,444
20,945,401
RGD:6480464 CTD
G
CDC16 cell division cycle 16
increases expression
EXP 13
115,000,362
115,038,150
RGD:6480464 CTD
G
CDC20 cell division cycle 20
decreases expression
EXP 1
43,824,626
43,828,874
RGD:6480464 CTD
G
CDC20B cell division cycle 20B
decreases expression
EXP 5
54,408,799
54,469,005
RGD:6480464 CTD
G
CDC25A cell division cycle 25A
decreases expression
EXP 3
48,198,668
48,229,801
RGD:6480464 CTD
G
CDC25B cell division cycle 25B
decreases expression
EXP 20
3,776,401
3,786,762
RGD:6480464 CTD
G
CDC27 cell division cycle 27
increases expression
EXP 17
45,195,310
45,266,665
RGD:6480464 CTD
G
CDC42EP4 CDC42 effector protein (Rho GTPase binding) 4
decreases expression
EXP 17
71,279,763
71,308,143
RGD:6480464 CTD
G
CDC6 cell division cycle 6
increases expression
EXP 17
38,444,146
38,459,413
RGD:6480464 CTD
G
CDC7 cell division cycle 7
decreases expression
EXP 1
91,966,404
91,991,321
RGD:6480464 CTD
G
CDCA2 cell division cycle associated 2
decreases expression
EXP 8
25,316,513
25,365,425
RGD:6480464 CTD
G
CDCA3 cell division cycle associated 3
decreases expression
ISO 12
6,957,972
6,960,456
RGD:6480464 CTD
G
CDCA4 cell division cycle associated 4
increases expression
EXP 14
105,475,910
105,487,425
RGD:6480464 CTD
G
CDCA5 cell division cycle associated 5
decreases expression
EXP 11
64,844,927
64,851,615
RGD:6480464 CTD
G
CDCA7 cell division cycle associated 7
decreases expression
EXP 2
174,219,561
174,233,718
RGD:6480464 CTD
G
CDCA7L cell division cycle associated 7-like
increases expression
EXP 7
21,940,517
21,985,542
RGD:6480464 CTD
G
CDH1 cadherin 1, type 1, E-cadherin (epithelial)
decreases expression
EXP 16
68,771,195
68,869,444
RGD:6480464 CTD
G
CDH10 cadherin 10, type 2 (T2-cadherin)
increases expression
EXP 5
24,487,209
24,645,085
RGD:6480464 CTD
G
CDH12 cadherin 12, type 2 (N-cadherin 2)
decreases expression
EXP 5
21,750,973
22,853,731
RGD:6480464 CTD
G
CDH18 cadherin 18, type 2
increases expression
EXP 5
19,473,140
19,988,353
RGD:6480464 CTD
G
CDH2 cadherin 2, type 1, N-cadherin (neuronal)
decreases expression
EXP 18
25,530,930
25,757,445
RGD:6480464 CTD
G
CDHR2 cadherin-related family member 2
decreases expression
EXP 5
175,969,512
176,022,769
RGD:6480464 CTD
G
CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase
decreases expression
EXP 16
29,869,678
29,874,578
RGD:6480464 CTD
G
CDK18 cyclin-dependent kinase 18
decreases expression
EXP 1
205,473,684
205,501,921
RGD:6480464 CTD
G
CDK2 cyclin-dependent kinase 2
decreases expression
EXP 12
56,360,556
56,366,568
RGD:6480464 CTD
G
CDK2AP2 cyclin-dependent kinase 2 associated protein 2
increases expression
EXP 11
67,273,968
67,276,102
RGD:6480464 CTD
G
CDK4 cyclin-dependent kinase 4
decreases expression
ISO 12
58,141,510
58,146,230
RGD:6480464 CTD
G
CDK4 cyclin-dependent kinase 4
increases expression
EXP 12
58,141,510
58,146,230
RGD:6480464 CTD
G
CDK5 cyclin-dependent kinase 5
decreases expression
EXP 7
150,750,899
150,755,052
RGD:6480464 CTD
G
CDK5RAP2 CDK5 regulatory subunit associated protein 2
increases expression
EXP 9
123,151,147
123,342,437
RGD:6480464 CTD
G
CDK7 cyclin-dependent kinase 7
increases expression
EXP 5
68,530,622
68,573,257
RGD:6480464 CTD
G
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP 6
36,644,237
36,655,116
RGD:6480464 CTD
G
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP 12
12,870,302
12,875,305
RGD:6480464 CTD
G
CDKN2AIP CDKN2A interacting protein
increases expression
EXP 4
184,365,789
184,369,049
RGD:6480464 CTD
G
CDKN2C cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
decreases expression
EXP 1
51,434,367
51,440,309
RGD:6480464 CTD
G
CDKN3 cyclin-dependent kinase inhibitor 3
affects expression
EXP 14
54,863,673
54,886,936
RGD:6480464 CTD
G
CDO1 cysteine dioxygenase, type I
decreases expression
EXP 5
115,140,430
115,152,405
RGD:6480464 CTD
G
CDR2 cerebellar degeneration-related protein 2, 62kDa
decreases expression
ISO 16
22,357,257
22,385,938
RGD:6480464 CTD
G
CDR2 cerebellar degeneration-related protein 2, 62kDa
increases expression
EXP 16
22,357,257
22,385,938
RGD:6480464 CTD
G
CDRT4 CMT1A duplicated region transcript 4
increases expression
EXP 17
15,339,332
15,370,925
RGD:6480464 CTD
G
CDT1 chromatin licensing and DNA replication factor 1
decreases expression
EXP 16
88,870,186
88,875,666
RGD:6480464 CTD
G
CDV3 CDV3 homolog (mouse)
increases expression
EXP 3
133,292,434
133,309,118
RGD:6480464 CTD
G
CDYL chromodomain protein, Y-like
increases expression
EXP 6
4,706,393
4,955,778
RGD:6480464 CTD
G
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
decreases expression
EXP 19
43,011,458
43,032,661
RGD:6480464 CTD
G
CEBPA CCAAT/enhancer binding protein (C/EBP), alpha
decreases expression
EXP 19
33,790,840
33,793,430
RGD:6480464 CTD
G
CEBPB CCAAT/enhancer binding protein (C/EBP), beta
increases expression
EXP 20
48,807,120
48,809,227
RGD:6480464 CTD
G
CEBPG CCAAT/enhancer binding protein (C/EBP), gamma
increases expression
EXP 19
33,864,575
33,873,592
RGD:6480464 CTD
G
CEBPZ CCAAT/enhancer binding protein (C/EBP), zeta
increases expression
EXP 2
37,428,772
37,458,740
RGD:6480464 CTD
G
CELF1 CUGBP, Elav-like family member 1
decreases expression
EXP 11
47,487,489
47,574,792
RGD:6480464 CTD
G
CELF6 CUGBP, Elav-like family member 6
increases expression
EXP 15
72,577,068
72,612,525
RGD:6480464 CTD
G
CELSR2 cadherin, EGF LAG seven-pass G-type receptor 2
decreases expression
EXP 1
109,792,641
109,818,378
RGD:6480464 CTD
G
CENPE centromere protein E, 312kDa
decreases expression
EXP 4
104,026,963
104,119,566
RGD:6480464 CTD
G
CENPF centromere protein F, 350/400kDa
decreases expression
EXP 1
214,776,532
214,837,914
RGD:6480464 CTD
G
CENPH centromere protein H
decreases expression
EXP 5
68,485,375
68,506,184
RGD:6480464 CTD
G
CENPI centromere protein I
decreases expression
EXP X
100,354,798
100,417,978
RGD:6480464 CTD
G
CENPJ centromere protein J
increases expression
EXP 13
25,456,412
25,497,027
RGD:6480464 CTD
G
CENPK centromere protein K
decreases expression
EXP 5
64,813,593
64,858,995
RGD:6480464 CTD
G
CENPK centromere protein K
decreases expression
ISO 5
64,813,593
64,858,995
RGD:6480464 CTD
G
CENPM centromere protein M
decreases expression
EXP 22
42,334,741
42,343,148
RGD:6480464 CTD
G
CENPQ centromere protein Q
decreases expression
EXP 6
49,431,096
49,460,820
RGD:6480464 CTD
G
CENPV centromere protein V
decreases expression
EXP 17
16,245,848
16,256,812
RGD:6480464 CTD
G
CENPW centromere protein W
decreases expression
EXP 6
126,661,253
126,669,754
RGD:6480464 CTD
G
CEP112 centrosomal protein 112kDa
increases expression
EXP 17
63,631,658
64,188,212
RGD:6480464 CTD
G
CEP120 centrosomal protein 120kDa
increases expression
EXP 5
122,680,579
122,759,286
RGD:6480464 CTD
G
CEP164 centrosomal protein 164kDa
increases expression
EXP 11
117,198,571
117,283,982
RGD:6480464 CTD
G
CEP19 centrosomal protein 19kDa
increases expression
EXP 3
196,433,148
196,439,123
RGD:6480464 CTD
G
CEP290 centrosomal protein 290kDa
increases expression
EXP 12
88,442,790
88,535,993
RGD:6480464 CTD
G
CEP57 centrosomal protein 57kDa
increases expression
EXP 11
95,523,625
95,565,857
RGD:6480464 CTD
G
CEP63 centrosomal protein 63kDa
increases expression
EXP 3
134,204,575
134,293,855
RGD:6480464 CTD
G
CEP68 centrosomal protein 68kDa
decreases expression
EXP 2
65,283,495
65,314,142
RGD:6480464 CTD
G
CEP95 centrosomal protein 95kDa
increases expression
EXP 17
62,503,158
62,534,064
RGD:6480464 CTD
G
CERK ceramide kinase
decreases expression
EXP 22
47,080,307
47,134,152
RGD:6480464 CTD
G
CERS2 ceramide synthase 2
decreases expression
EXP 1
150,937,649
150,947,479
RGD:6480464 CTD
G
CERS4 ceramide synthase 4
decreases expression
EXP 19
8,274,217
8,327,305
RGD:6480464 CTD
G
CERS5 ceramide synthase 5
increases expression
EXP 12
50,523,581
50,561,097
RGD:6480464 CTD
G
CES1 carboxylesterase 1
increases expression
EXP 16
55,836,763
55,867,075
RGD:6480464 CTD
G
CES2 carboxylesterase 2
decreases expression
EXP 16
66,968,347
66,978,999
RGD:6480464 CTD
G
CFB complement factor B
decreases expression
EXP 6
31,913,721
31,919,861
RGD:6480464 CTD
G
CFH complement factor H
decreases expression
EXP 1
196,621,008
196,716,634
RGD:6480464 CTD
G
CFHR2 complement factor H-related 2
decreases expression
EXP 1
196,912,934
196,928,356
RGD:6480464 CTD
G
CFI complement factor I
decreases expression
EXP 4
110,661,848
110,723,335
RGD:6480464 CTD
G
CGN cingulin
decreases expression
EXP 1
151,483,862
151,511,168
RGD:6480464 CTD
G
CGNL1 cingulin-like 1
decreases expression
EXP 15
57,668,703
57,842,925
RGD:6480464 CTD
G
CGRRF1 cell growth regulator with ring finger domain 1
increases expression
EXP 14
54,976,587
55,005,334
RGD:6480464 CTD
G
CHAC1 ChaC, cation transport regulator homolog 1 (E. coli)
increases expression
EXP 15
41,245,636
41,248,717
RGD:6480464 CTD
G
CHAC2 ChaC, cation transport regulator homolog 2 (E. coli)
decreases expression
EXP 2
53,994,929
54,002,287
RGD:6480464 CTD
G
CHAF1A chromatin assembly factor 1, subunit A (p150)
decreases expression
EXP 19
4,402,660
4,443,394
RGD:6480464 CTD
G
CHCHD1 coiled-coil-helix-coiled-coil-helix domain containing 1
decreases expression
EXP 10
75,541,808
75,543,406
RGD:6480464 CTD
G
CHCHD10 coiled-coil-helix-coiled-coil-helix domain containing 10
increases expression
EXP 22
24,108,021
24,110,141
RGD:6480464 CTD
G
CHCHD2 coiled-coil-helix-coiled-coil-helix domain containing 2
increases expression
EXP 7
56,169,266
56,174,187
RGD:6480464 CTD
G
CHCHD3 coiled-coil-helix-coiled-coil-helix domain containing 3
increases expression
EXP 7
132,469,623
132,766,833
RGD:6480464 CTD
G
CHCHD6 coiled-coil-helix-coiled-coil-helix domain containing 6
increases expression
EXP 3
126,423,063
126,679,263
RGD:6480464 CTD
G
CHD1 chromodomain helicase DNA binding protein 1
increases expression
EXP 5
98,190,908
98,262,238
RGD:6480464 CTD
G
CHD1L chromodomain helicase DNA binding protein 1-like
decreases expression
EXP 1
146,714,291
146,767,447
RGD:6480464 CTD
G
CHD2 chromodomain helicase DNA binding protein 2
increases expression
EXP 15
93,443,551
93,571,237
RGD:6480464 CTD
G
CHEK1 checkpoint kinase 1
decreases expression
EXP 11
125,495,031
125,546,150
RGD:6480464 CTD
G
CHI3L1 chitinase 3-like 1 (cartilage glycoprotein-39)
decreases expression
EXP 1
203,148,059
203,155,922
RGD:6480464 CTD
G
CHI3L2 chitinase 3-like 2
increases expression
EXP 1
111,770,281
111,786,062
RGD:6480464 CTD
G
CHIC2 cysteine-rich hydrophobic domain 2
increases expression
EXP 4
54,875,956
54,930,815
RGD:6480464 CTD
G
CHML choroideremia-like (Rab escort protein 2)
decreases expression
EXP 1
241,792,166
241,799,232
RGD:6480464 CTD
G
CHMP4A charged multivesicular body protein 4A
increases expression
EXP 14
24,678,787
24,683,036
RGD:6480464 CTD
G
CHMP5 charged multivesicular body protein 5
increases expression
EXP 9
33,264,877
33,282,067
RGD:6480464 CTD
G
CHN1 chimerin 1
increases expression
EXP 2
175,664,042
175,870,107
RGD:6480464 CTD
G
CHN2 chimerin 2
decreases expression
EXP 7
29,234,121
29,553,944
RGD:6480464 CTD
G
CHORDC1 cysteine and histidine-rich domain (CHORD) containing 1
increases expression
EXP 11
89,933,597
89,956,532
RGD:6480464 CTD
G
CHPF chondroitin polymerizing factor
increases expression
EXP 2
220,403,669
220,408,487
RGD:6480464 CTD
G
CHPT1 choline phosphotransferase 1
decreases expression
EXP 12
102,091,417
102,122,846
RGD:6480464 CTD
G
CHST1 carbohydrate (keratan sulfate Gal-6) sulfotransferase 1
increases expression
EXP 11
45,669,239
45,687,206
RGD:6480464 CTD
G
CHST11 carbohydrate (chondroitin 4) sulfotransferase 11
increases expression
EXP 12
104,850,692
105,155,792
RGD:6480464 CTD
G
CHST13 carbohydrate (chondroitin 4) sulfotransferase 13
decreases expression
EXP 3
126,243,131
126,262,134
RGD:6480464 CTD
G
CHST14 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
decreases expression
EXP 15
40,763,160
40,765,357
RGD:6480464 CTD
G
CHST3 carbohydrate (chondroitin 6) sulfotransferase 3
increases expression
EXP 10
73,724,120
73,773,322
RGD:6480464 CTD
G
CHST9 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9
decreases expression
EXP 18
24,495,595
24,765,302
RGD:6480464 CTD
G
CHSY1 chondroitin sulfate synthase 1
increases expression
EXP 15
101,715,928
101,792,137
RGD:6480464 CTD
G
CHTF18 CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)
decreases expression
EXP 16
838,622
848,074
RGD:6480464 CTD
G
CIDEB cell death-inducing DFFA-like effector b
decreases expression
EXP 14
24,774,393
24,780,576
RGD:6480464 CTD
G
CIDEC cell death-inducing DFFA-like effector c
decreases expression
EXP 3
9,908,394
9,921,938
RGD:6480464 CTD
G
CIRH1A cirrhosis, autosomal recessive 1A (cirhin)
increases expression
EXP 16
69,166,499
69,202,937
RGD:6480464 CTD
G
CISD2 CDGSH iron sulfur domain 2
increases expression
EXP 4
103,790,135
103,813,964
RGD:6480464 CTD
G
CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP 6
139,693,392
139,695,787
RGD:6480464 CTD
G
CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO 6
139,693,392
139,695,787
RGD:6480464 CTD
G
CITED4 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
decreases expression
EXP 1
41,326,728
41,328,018
RGD:6480464 CTD
G
CIZ1 CDKN1A interacting zinc finger protein 1
increases expression
EXP 9
130,928,344
130,966,662
RGD:6480464 CTD
G
CKAP2 cytoskeleton associated protein 2
decreases expression
EXP 13
53,029,495
53,050,763
RGD:6480464 CTD
G
CKAP2L cytoskeleton associated protein 2-like
decreases expression
EXP 2
113,495,444
113,522,254
RGD:6480464 CTD
G
CKAP4 cytoskeleton-associated protein 4
increases expression
EXP 12
106,631,659
106,641,713
RGD:6480464 CTD
G
CKB creatine kinase, brain
decreases expression
EXP 14
103,985,995
103,989,196
RGD:6480464 CTD
G
CKLF chemokine-like factor
decreases expression
EXP 16
66,586,466
66,600,190
RGD:6480464 CTD
G
CKS2 CDC28 protein kinase regulatory subunit 2
decreases expression
EXP 9
91,926,113
91,931,618
RGD:6480464 CTD
G
CLCC1 chloride channel CLIC-like 1
increases expression
EXP 1
109,472,130
109,506,111
RGD:6480464 CTD
G
CLCN3 chloride channel, voltage-sensitive 3
decreases expression
EXP 4
170,541,672
170,644,338
RGD:6480464 CTD
G
CLCN5 chloride channel, voltage-sensitive 5
decreases expression
EXP X
49,687,225
49,863,892
RGD:6480464 CTD
G
CLCN7 chloride channel, voltage-sensitive 7
increases expression
EXP 16
1,494,934
1,525,085
RGD:6480464 CTD
G
CLDN14 claudin 14
decreases expression
EXP 21
37,832,919
37,948,867
RGD:6480464 CTD
G
CLDN3 claudin 3
decreases expression
EXP 7
73,183,327
73,184,600
RGD:6480464 CTD
G
CLEC3B C-type lectin domain family 3, member B
decreases expression
EXP 3
45,067,759
45,077,563
RGD:6480464 CTD
G
CLGN calmegin
increases expression
EXP 4
141,309,607
141,348,815
RGD:6480464 CTD
G
CLHC1 clathrin heavy chain linker domain containing 1
increases expression
EXP 2
55,399,683
55,459,699
RGD:6480464 CTD
G
CLIC1 chloride intracellular channel 1
increases expression
EXP 6
31,698,358
31,704,341
RGD:6480464 CTD
G
CLIC2 chloride intracellular channel 2
increases expression
EXP X
154,505,500
154,563,986
RGD:6480464 CTD
G
CLIC3 chloride intracellular channel 3
decreases expression
EXP 9
139,889,060
139,891,024
RGD:6480464 CTD
G
CLIC4 chloride intracellular channel 4
increases expression
EXP 1
25,071,760
25,170,815
RGD:6480464 CTD
G
CLINT1 clathrin interactor 1
increases expression
EXP 5
157,212,751
157,286,183
RGD:6480464 CTD
G
CLIP1 CAP-GLY domain containing linker protein 1
increases expression
EXP 12
122,755,981
122,907,116
RGD:6480464 CTD
G
CLIP2 CAP-GLY domain containing linker protein 2
increases expression
EXP 7
73,703,805
73,820,273
RGD:6480464 CTD
G
CLIP4 CAP-GLY domain containing linker protein family, member 4
increases expression
EXP 2
29,338,308
29,406,679
RGD:6480464 CTD
G
CLK1 CDC-like kinase 1
increases expression
EXP 2
201,717,732
201,729,467
RGD:6480464 CTD
G
CLMN calmin (calponin-like, transmembrane)
decreases expression
EXP 14
95,648,276
95,786,245
RGD:6480464 CTD
G
CLN3 ceroid-lipofuscinosis, neuronal 3
decreases expression
EXP 16
28,488,600
28,503,623
RGD:6480464 CTD
G
CLN5 ceroid-lipofuscinosis, neuronal 5
decreases expression
EXP 13
77,566,059
77,576,652
RGD:6480464 CTD
G
CLN8 ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
increases expression
EXP 8
1,711,870
1,734,736
RGD:6480464 CTD
G
CLRN3 clarin 3
decreases expression
EXP 10
129,676,114
129,691,211
RGD:6480464 CTD
G
CLTCL1 clathrin, heavy chain-like 1
decreases expression
EXP 22
19,166,986
19,279,239
RGD:6480464 CTD
G
CLYBL citrate lyase beta like
decreases expression
EXP 13
100,258,919
100,549,388
RGD:6480464 CTD
G
CMBL carboxymethylenebutenolidase homolog (Pseudomonas)
decreases expression
EXP 5
10,277,707
10,308,168
RGD:6480464 CTD
G
CMPK2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial
decreases expression
ISO 2
6,980,684
7,006,766
RGD:6480464 CTD
G
CMSS1 cms1 ribosomal small subunit homolog (yeast)
increases expression
EXP 3
99,536,678
99,897,476
RGD:6480464 CTD
G
CMTM6 CKLF-like MARVEL transmembrane domain containing 6
decreases expression
EXP 3
32,522,804
32,544,403
RGD:6480464 CTD
G
CNDP2 CNDP dipeptidase 2 (metallopeptidase M20 family)
increases expression
EXP 18
72,163,500
72,190,689
RGD:6480464 CTD
G
CNGA1 cyclic nucleotide gated channel alpha 1
decreases expression
EXP 4
47,937,994
48,014,961
RGD:6480464 CTD
G
CNIH4 cornichon homolog 4 (Drosophila)
increases expression
EXP 1
224,544,595
224,563,691
RGD:6480464 CTD
G
CNKSR1 connector enhancer of kinase suppressor of Ras 1
increases expression
EXP 1
26,503,981
26,516,375
RGD:6480464 CTD
G
COA3 cytochrome c oxidase assembly factor 3
decreases expression
EXP 17
40,949,652
40,950,704
RGD:6480464 CTD
G
CPED1 cadherin-like and PC-esterase domain containing 1
decreases expression
EXP 7
120,628,751
120,937,498
RGD:6480464 CTD
G
CREBRF CREB3 regulatory factor
increases expression
EXP 5
172,483,355
172,566,291
RGD:6480464 CTD
G
CTBP1-AS1 CTBP1 antisense RNA 1 (head to head)
increases expression
EXP 4
1,243,228
1,246,795
RGD:6480464 CTD
G
FAM213A family with sequence similarity 213, member A
decreases expression
EXP 10
82,167,585
82,192,753
RGD:6480464 CTD
G
FAM219A family with sequence similarity 219, member A
increases expression
EXP 9
34,398,182
34,458,568
RGD:6480464 CTD
G
FAM220A family with sequence similarity 220, member A
increases expression
EXP 7
6,369,040
6,388,590
RGD:6480464 CTD
G
FAXDC2 fatty acid hydroxylase domain containing 2
decreases expression
EXP 5
154,198,052
154,230,213
RGD:6480464 CTD
G
FUOM fucose mutarotase
decreases expression
EXP 10
135,168,658
135,171,529
RGD:6480464 CTD
G
GID4 GID complex subunit 4, VID24 homolog (S. cerevisiae)
increases expression
EXP 17
17,942,611
17,971,718
RGD:6480464 CTD
G
HID1 HID1 domain containing
increases expression
EXP 17
72,946,839
72,968,900
RGD:6480464 CTD
G
IDNK idnK, gluconokinase homolog (E. coli)
decreases expression
EXP 9
86,237,964
86,259,045
RGD:6480464 CTD
G
LDLRAD4 low density lipoprotein receptor class A domain containing 4
decreases expression
EXP 18
13,218,786
13,652,753
RGD:6480464 CTD
G
LSMEM1 leucine-rich single-pass membrane protein 1
increases expression
EXP 7
112,120,908
112,130,943
RGD:6480464 CTD
G
MAP3K7CL MAP3K7 C-terminal like
decreases expression
EXP 21
30,452,873
30,548,204
RGD:6480464 CTD
G
MCUR1 mitochondrial calcium uniporter regulator 1
increases expression
EXP 6
13,786,781
13,814,792
RGD:6480464 CTD
G
MGME1 mitochondrial genome maintenance exonuclease 1
decreases expression
EXP 20
17,949,762
17,971,761
RGD:6480464 CTD
G
MPC2 mitochondrial pyruvate carrier 2
decreases expression
EXP 1
167,885,913
167,906,307
RGD:6480464 CTD
G
MRGBP MRG/MORF4L binding protein
increases expression
EXP 20
61,427,805
61,431,945
RGD:6480464 CTD
G
MSANTD3 Myb/SANT-like DNA-binding domain containing 3
increases expression
EXP 9
103,189,495
103,214,016
RGD:6480464 CTD
G
NMRK1 nicotinamide riboside kinase 1
increases expression
EXP 9
77,676,116
77,703,133
RGD:6480464 CTD
G
PROSER2 proline and serine-rich protein 2
increases expression
EXP 10
11,865,397
11,914,276
RGD:6480464 CTD
G
RHNO1 RAD9-HUS1-RAD1 interacting nuclear orphan 1
increases expression
EXP 12
2,985,424
2,998,691
RGD:6480464 CTD
G
RORA RAR-related orphan receptor A
decreases expression
ISO 15
60,780,483
61,521,502
RGD:6480464 CTD
G
RPP25L ribonuclease P/MRP 25kDa subunit-like
decreases expression
EXP 9
34,610,482
34,612,110
RGD:6480464 CTD
G
SDE2 SDE2 telomere maintenance homolog (S. pombe)
increases expression
EXP 1
226,170,403
226,187,066
RGD:6480464 CTD
G
SERTAD4-AS1 SERTAD4 antisense RNA 1
decreases expression
EXP 1
210,404,804
210,407,466
RGD:6480464 CTD
G
SKIDA1 SKI/DACH domain containing 1
decreases expression
EXP 10
21,802,407
21,814,611
RGD:6480464 CTD
G
SLC18B1 solute carrier family 18, subfamily B, member 1
decreases expression
EXP 6
133,090,507
133,119,747
RGD:6480464 CTD
G
SLC35F6 solute carrier family 35, member F6
increases expression
EXP 2
26,987,142
27,004,099
RGD:6480464 CTD
G
SMCO4 single-pass membrane protein with coiled-coil domains 4
increases expression
EXP 11
93,211,638
93,276,546
RGD:6480464 CTD
G
SMIM14 small integral membrane protein 14
increases expression
EXP 4
39,552,550
39,640,481
RGD:6480464 CTD
G
SMIM3 small integral membrane protein 3
decreases expression
EXP 5
150,157,508
150,176,298
RGD:6480464 CTD
G
SMIM8 small integral membrane protein 8
decreases expression
EXP 6
88,032,306
88,052,043
RGD:6480464 CTD
G
SPDL1 spindle apparatus coiled-coil protein 1
decreases expression
EXP 5
169,010,638
169,031,782
RGD:6480464 CTD
G
SPRTN SprT-like N-terminal domain
increases expression
EXP 1
231,473,682
231,490,769
RGD:6480464 CTD
G
ST7L suppression of tumorigenicity 7 like
increases expression
EXP 1
113,066,140
113,162,040
RGD:6480464 CTD
G
ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
increases expression
EXP 5
100,142,639
100,238,987
RGD:6480464 CTD
G
STAC SH3 and cysteine rich domain
increases expression
EXP 3
36,422,097
36,589,496
RGD:6480464 CTD
G
STAG1 stromal antigen 1
increases expression
EXP 3
136,055,999
136,471,245
RGD:6480464 CTD
G
STAM signal transducing adaptor molecule (SH3 domain and ITAM motif) 1
increases expression
EXP 10
17,686,124
17,758,823
RGD:6480464 CTD
G
STAM2 signal transducing adaptor molecule (SH3 domain and ITAM motif) 2
increases expression
EXP 2
152,973,315
153,032,506
RGD:6480464 CTD
G
STAMBPL1 STAM binding protein-like 1
increases expression
EXP 10
90,639,944
90,683,259
RGD:6480464 CTD
G
STAP2 signal transducing adaptor family member 2
decreases expression
EXP 19
4,324,040
4,338,847
RGD:6480464 CTD
G
STARD5 StAR-related lipid transfer (START) domain containing 5
decreases expression
EXP 15
81,605,007
81,616,524
RGD:6480464 CTD
G
STPG1 sperm-tail PG-rich repeat containing 1
increases expression
EXP 1
24,683,489
24,741,587
RGD:6480464 CTD
G
SUCO SUN domain containing ossification factor
increases expression
EXP 1
172,502,260
172,580,973
RGD:6480464 CTD
G
TANGO2 transport and golgi organization 2 homolog (Drosophila)
increases expression
EXP 22
20,008,631
20,053,447
RGD:6480464 CTD
G
TCAIM T cell activation inhibitor, mitochondrial
decreases expression
EXP 3
44,379,611
44,450,940
RGD:6480464 CTD
G
THEM6 thioesterase superfamily member 6
decreases expression
EXP 8
143,808,621
143,818,350
RGD:6480464 CTD
G
THG1L tRNA-histidine guanylyltransferase 1-like (S. cerevisiae)
increases expression
EXP 5
157,158,323
157,166,772
RGD:6480464 CTD
G
THSD7A thrombospondin, type I, domain containing 7A
increases expression
EXP 7
11,410,062
11,871,824
RGD:6480464 CTD
G
THYN1 thymocyte nuclear protein 1
decreases expression
EXP 11
134,118,173
134,123,260
RGD:6480464 CTD
G
TICAM2 toll-like receptor adaptor molecule 2
increases expression
EXP 5
114,914,339
114,938,176
RGD:6480464 CTD
G
TIGD1 tigger transposable element derived 1
increases expression
EXP 2
233,412,779
233,415,226
RGD:6480464 CTD
G
TIMELESS timeless circadian clock
decreases expression
EXP 12
56,810,157
56,843,200
RGD:6480464 CTD
G
TIMM17A translocase of inner mitochondrial membrane 17 homolog A (yeast)
increases expression
EXP 1
201,924,619
201,939,789
RGD:6480464 CTD
G
TMA16 translation machinery associated 16 homolog (S. cerevisiae)
increases expression
EXP 4
164,415,673
164,441,691
RGD:6480464 CTD
G
TMEM243 transmembrane protein 243, mitochondrial
increases expression
EXP 7
86,825,478
86,849,031
RGD:6480464 CTD
G
TMEM251 transmembrane protein 251
increases expression
EXP 14
93,651,296
93,653,431
RGD:6480464 CTD
G
TMEM256 transmembrane protein 256
decreases expression
EXP 17
7,306,293
7,307,450
RGD:6480464 CTD
G
TMEM258 transmembrane protein 258
increases expression
EXP 11
61,556,602
61,560,085
RGD:6480464 CTD
G
TMEM259 transmembrane protein 259
decreases expression
EXP 19
1,009,650
1,021,141
RGD:6480464 CTD
G
USB1 U6 snRNA biogenesis 1
decreases expression
EXP 16
58,035,277
58,055,527
RGD:6480464 CTD
G
VIPAS39 VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
increases expression
EXP 14
77,893,018
77,923,983
RGD:6480464 CTD
G
WBP1L WW domain binding protein 1-like
decreases expression
EXP 10
104,503,727
104,576,021
RGD:6480464 CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest 
